Frequencies for first 10,000 rows of pt variable in reac2004q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 9 0.09 0.09 ABDOMINAL ADHESIONS | 3 0.03 0.12 ABDOMINAL DISCOMFORT | 2 0.02 0.14 ABDOMINAL DISTENSION | 16 0.16 0.30 ABDOMINAL INFECTION | 1 0.01 0.31 ABDOMINAL MASS | 1 0.01 0.32 ABDOMINAL PAIN | 33 0.33 0.65 ABDOMINAL PAIN LOWER | 2 0.02 0.67 ABDOMINAL PAIN UPPER | 17 0.17 0.84 ABDOMINAL PANNICULECTOMY | 1 0.01 0.85 ABDOMINAL RIGIDITY | 1 0.01 0.86 ABDOMINAL WALL ABSCESS | 1 0.01 0.87 ABNORMAL BEHAVIOUR | 20 0.20 1.07 ABNORMAL DREAMS | 3 0.03 1.10 ABNORMAL FAECES | 1 0.01 1.11 ABNORMAL PALMAR/PLANTAR CREASES | 1 0.01 1.12 ABNORMAL SENSATION IN EYE | 1 0.01 1.13 ABORTION INDUCED | 3 0.03 1.16 ABORTION SPONTANEOUS | 3 0.03 1.19 ABORTION THREATENED | 1 0.01 1.20 ABSCESS | 5 0.05 1.25 ABULIA | 1 0.01 1.26 ACCELERATED HYPERTENSION | 1 0.01 1.27 ACCIDENTAL EXPOSURE | 5 0.05 1.32 ACCIDENTAL NEEDLE STICK | 1 0.01 1.33 ACCIDENTAL OVERDOSE | 11 0.11 1.44 ACID FAST BACILLI INFECTION | 2 0.02 1.46 ACIDOSIS | 4 0.04 1.50 ACINETOBACTER INFECTION | 1 0.01 1.51 ACNE | 1 0.01 1.52 ACOUSTIC NEUROMA | 2 0.02 1.54 ACTIVATED PARTIAL THROMBOPLASTIN TIME | 1 0.01 1.55 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 1.57 ACTIVITIES OF DAILY LIVING IMPAIRED | 7 0.07 1.64 ACUTE CORONARY SYNDROME | 2 0.02 1.66 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 1.68 ACUTE MYELOID LEUKAEMIA | 8 0.08 1.76 ACUTE MYELOMONOCYTIC LEUKAEMIA | 1 0.01 1.77 ACUTE MYOCARDIAL INFARCTION | 10 0.10 1.87 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 1.88 ACUTE PSYCHOSIS | 2 0.02 1.90 ACUTE PULMONARY OEDEMA | 10 0.10 2.00 ACUTE RESPIRATORY DISTRESS SYNDROME | 21 0.21 2.21 ACUTE RESPIRATORY FAILURE | 2 0.02 2.23 ADACTYLY | 1 0.01 2.24 ADRENAL DISORDER | 1 0.01 2.25 AFFECT LABILITY | 1 0.01 2.26 AGEUSIA | 3 0.03 2.29 AGGRESSION | 12 0.12 2.41 AGITATION | 18 0.18 2.59 AGORAPHOBIA | 1 0.01 2.60 AGRANULOCYTOSIS | 11 0.11 2.71 AKATHISIA | 1 0.01 2.72 AKINESIA | 1 0.01 2.73 ALANINE AMINOTRANSFERASE DECREASED | 1 0.01 2.74 ALANINE AMINOTRANSFERASE INCREASED | 44 0.44 3.18 ALCOHOL INTERACTION | 1 0.01 3.19 ALCOHOL POISONING | 1 0.01 3.20 ALCOHOL USE | 3 0.03 3.23 ALCOHOL WITHDRAWAL SYNDROME | 3 0.03 3.26 ALCOHOLISM | 3 0.03 3.29 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.30 ALOPECIA | 13 0.13 3.43 ALPHA 1 FOETOPROTEIN DECREASED | 1 0.01 3.44 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.45 ALVEOLITIS | 1 0.01 3.46 ALVEOLITIS ALLERGIC | 1 0.01 3.47 AMENORRHOEA | 1 0.01 3.48 AMMONIA INCREASED | 2 0.02 3.50 AMNESIA | 14 0.14 3.64 AMNIOCENTESIS ABNORMAL | 1 0.01 3.65 AMOEBIC COLITIS | 1 0.01 3.66 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 3.67 ANAEMIA | 43 0.43 4.10 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 4.12 ANAEMIA MACROCYTIC | 3 0.03 4.15 ANAESTHETIC COMPLICATION | 2 0.02 4.17 ANAESTHETIC COMPLICATION CARDIAC | 1 0.01 4.18 ANAL ABSCESS | 1 0.01 4.19 ANAL CANCER | 2 0.02 4.21 ANAL DISCOMFORT | 1 0.01 4.22 ANAL FISTULA | 1 0.01 4.23 ANAPHYLACTIC REACTION | 8 0.08 4.31 ANAPHYLACTIC SHOCK | 8 0.08 4.39 ANASTOMOTIC HAEMORRHAGE | 1 0.01 4.40 ANEURYSM | 1 0.01 4.41 ANGER | 8 0.08 4.49 ANGINA PECTORIS | 7 0.07 4.56 ANGINA UNSTABLE | 4 0.04 4.60 ANGIONEUROTIC OEDEMA | 11 0.11 4.71 ANGIOPATHY | 1 0.01 4.72 ANIMAL BITE | 1 0.01 4.73 ANION GAP ABNORMAL | 2 0.02 4.75 ANKYLOSING SPONDYLITIS | 1 0.01 4.76 ANOMALY OF EXTERNAL EAR CONGENITAL | 2 0.02 4.78 ANOREXIA | 33 0.33 5.11 ANORGASMIA | 1 0.01 5.12 ANOSMIA | 3 0.03 5.15 ANOXIA | 1 0.01 5.16 ANOXIC ENCEPHALOPATHY | 4 0.04 5.20 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.21 ANTIBODY TEST POSITIVE | 1 0.01 5.22 ANTICHOLINERGIC SYNDROME | 1 0.01 5.23 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 3 0.03 5.26 ANTINUCLEAR ANTIBODY POSITIVE | 5 0.05 5.31 ANTISOCIAL BEHAVIOUR | 1 0.01 5.32 ANURIA | 10 0.10 5.42 ANXIETY | 43 0.43 5.85 AORTA HYPOPLASIA | 1 0.01 5.86 AORTIC ANEURYSM | 2 0.02 5.88 AORTIC ANEURYSM RUPTURE | 1 0.01 5.89 AORTIC ATHEROSCLEROSIS | 3 0.03 5.92 AORTIC DISSECTION | 1 0.01 5.93 AORTIC STENOSIS | 3 0.03 5.96 AORTIC VALVE DISEASE MIXED | 1 0.01 5.97 AORTIC VALVE INCOMPETENCE | 6 0.06 6.03 APATHY | 4 0.04 6.07 APGAR SCORE ABNORMAL | 1 0.01 6.08 APGAR SCORE LOW | 5 0.05 6.13 APHAGIA | 2 0.02 6.15 APHASIA | 4 0.04 6.19 APHONIA | 2 0.02 6.21 APLASIA | 1 0.01 6.22 APLASIA PURE RED CELL | 3 0.03 6.25 APLASTIC ANAEMIA | 1 0.01 6.26 APNOEA | 7 0.07 6.33 APPENDICECTOMY | 1 0.01 6.34 APPENDICITIS | 2 0.02 6.36 APPLICATION SITE PAIN | 1 0.01 6.37 AREFLEXIA | 2 0.02 6.39 ARNOLD-CHIARI MALFORMATION | 1 0.01 6.40 ARRHYTHMIA | 13 0.13 6.53 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 6.55 ARTERIAL INJURY | 1 0.01 6.56 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 6.58 ARTERIAL STENOSIS | 1 0.01 6.59 ARTERIAL THROMBOSIS | 2 0.02 6.61 ARTERIAL THROMBOSIS LIMB | 1 0.01 6.62 ARTERIOSCLEROSIS | 2 0.02 6.64 ARTERIOSPASM CORONARY | 3 0.03 6.67 ARTERIOVENOUS FISTULA, ACQUIRED | 1 0.01 6.68 ARTERIOVENOUS MALFORMATION | 1 0.01 6.69 ARTERITIS | 2 0.02 6.71 ARTHRALGIA | 38 0.38 7.09 ARTHRITIS | 5 0.05 7.14 ARTHRITIS BACTERIAL | 1 0.01 7.15 ARTHRITIS INFECTIVE | 2 0.02 7.17 ARTHROPATHY | 3 0.03 7.20 ARTHROPOD STING | 1 0.01 7.21 ASCITES | 13 0.13 7.34 ASPARTATE AMINOTRANSFERASE INCREASED | 48 0.48 7.82 ASPERGILLOSIS | 3 0.03 7.85 ASPIRATION | 6 0.06 7.91 ASTERIXIS | 3 0.03 7.94 ASTHENIA | 83 0.83 8.77 ASTHMA | 16 0.16 8.93 ATAXIA | 11 0.11 9.04 ATELECTASIS | 2 0.02 9.06 ATHEROSCLEROSIS | 1 0.01 9.07 ATRIAL FIBRILLATION | 19 0.19 9.26 ATRIAL FLUTTER | 2 0.02 9.28 ATRIAL HYPERTROPHY | 1 0.01 9.29 ATRIOVENTRICULAR BLOCK | 4 0.04 9.33 ATRIOVENTRICULAR BLOCK COMPLETE | 5 0.05 9.38 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 9.41 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 4 0.04 9.45 ATYPICAL MYCOBACTERIAL INFECTION | 2 0.02 9.47 AUTOIMMUNE DISORDER | 1 0.01 9.48 AUTOIMMUNE HEPATITIS | 1 0.01 9.49 AUTOIMMUNE THYROIDITIS | 2 0.02 9.51 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 9.52 AV DISSOCIATION | 1 0.01 9.53 AXILLARY VEIN THROMBOSIS | 1 0.01 9.54 AZOTAEMIA | 3 0.03 9.57 B-CELL LYMPHOMA | 1 0.01 9.58 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 1 0.01 9.59 BACILLUS INFECTION | 1 0.01 9.60 BACK DISORDER | 1 0.01 9.61 BACK INJURY | 1 0.01 9.62 BACK PAIN | 31 0.31 9.93 BACTERAEMIA | 1 0.01 9.94 BACTERIA BLOOD IDENTIFIED | 1 0.01 9.95 BACTERIA SPUTUM IDENTIFIED | 1 0.01 9.96 BACTERIA STOOL IDENTIFIED | 2 0.02 9.98 BACTERIA URINE IDENTIFIED | 1 0.01 9.99 BACTERIAL CULTURE POSITIVE | 1 0.01 10.00 BACTERIAL INFECTION | 6 0.06 10.06 BACTERIAL SEPSIS | 1 0.01 10.07 BALANCE DISORDER | 8 0.08 10.15 BARRETT'S OESOPHAGUS | 2 0.02 10.17 BASAL CELL CARCINOMA | 5 0.05 10.22 BASE EXCESS NEGATIVE | 1 0.01 10.23 BASILAR ARTERY OCCLUSION | 1 0.01 10.24 BEHCET'S SYNDROME | 1 0.01 10.25 BENIGN COLONIC POLYP | 2 0.02 10.27 BENIGN HYDATIDIFORM MOLE | 1 0.01 10.28 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 10.29 BENIGN PROSTATIC HYPERPLASIA | 3 0.03 10.32 BENIGN SALIVARY GLAND NEOPLASM | 1 0.01 10.33 BEREAVEMENT | 1 0.01 10.34 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 10.35 BILE DUCT CANCER | 1 0.01 10.36 BILE DUCT OBSTRUCTION | 2 0.02 10.38 BILIARY NEOPLASM | 1 0.01 10.39 BILIARY TRACT DISORDER | 1 0.01 10.40 BILIRUBIN CONJUGATED INCREASED | 1 0.01 10.41 BIOPSY BONE MARROW ABNORMAL | 1 0.01 10.42 BIOPSY INTESTINE ABNORMAL | 1 0.01 10.43 BIOPSY KIDNEY ABNORMAL | 1 0.01 10.44 BIOPSY LIVER ABNORMAL | 2 0.02 10.46 BIOPSY SKIN ABNORMAL | 1 0.01 10.47 BIPOLAR DISORDER | 2 0.02 10.49 BIPOLAR I DISORDER | 4 0.04 10.53 BITE | 1 0.01 10.54 BLADDER CANCER | 2 0.02 10.56 BLADDER DISORDER | 2 0.02 10.58 BLADDER DISTENSION | 2 0.02 10.60 BLADDER NECROSIS | 2 0.02 10.62 BLADDER NEOPLASM | 1 0.01 10.63 BLASTOCYSTIS INFECTION | 1 0.01 10.64 BLEEDING TIME PROLONGED | 1 0.01 10.65 BLEPHAROSPASM | 1 0.01 10.66 BLINDNESS | 7 0.07 10.73 BLINDNESS UNILATERAL | 6 0.06 10.79 BLISTER | 3 0.03 10.82 BLOOD ALBUMIN DECREASED | 9 0.09 10.91 BLOOD ALCOHOL INCREASED | 1 0.01 10.92 BLOOD ALDOSTERONE DECREASED | 1 0.01 10.93 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 10.94 BLOOD ALKALINE PHOSPHATASE INCREASED | 32 0.32 11.26 BLOOD AMYLASE INCREASED | 6 0.06 11.32 BLOOD BETA-D-GLUCAN INCREASED | 1 0.01 11.33 BLOOD BICARBONATE DECREASED | 3 0.03 11.36 BLOOD BICARBONATE INCREASED | 1 0.01 11.37 BLOOD BILIRUBIN INCREASED | 16 0.16 11.53 BLOOD CALCIUM DECREASED | 2 0.02 11.55 BLOOD CALCIUM INCREASED | 2 0.02 11.57 BLOOD CHLORIDE DECREASED | 6 0.06 11.63 BLOOD CHLORIDE INCREASED | 2 0.02 11.65 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 11.66 BLOOD CHOLESTEROL INCREASED | 17 0.17 11.83 BLOOD CREATINE ABNORMAL | 1 0.01 11.84 BLOOD CREATINE INCREASED | 2 0.02 11.86 BLOOD CREATINE PHOSPHOKINASE INCREASED | 24 0.24 12.10 BLOOD CREATININE ABNORMAL | 2 0.02 12.12 BLOOD CREATININE DECREASED | 4 0.04 12.16 BLOOD CREATININE INCREASED | 36 0.36 12.52 BLOOD CULTURE POSITIVE | 5 0.05 12.57 BLOOD DISORDER | 1 0.01 12.58 BLOOD ETHANOL | 1 0.01 12.59 BLOOD FIBRINOGEN INCREASED | 1 0.01 12.60 BLOOD GASES ABNORMAL | 1 0.01 12.61 BLOOD GLUCOSE ABNORMAL | 2 0.02 12.63 BLOOD GLUCOSE DECREASED | 11 0.11 12.74 BLOOD GLUCOSE FLUCTUATION | 2 0.02 12.76 BLOOD GLUCOSE INCREASED | 37 0.37 13.13 BLOOD HIV RNA | 1 0.01 13.14 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 13.15 BLOOD IMMUNOGLOBULIN A INCREASED | 2 0.02 13.17 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.18 BLOOD IMMUNOGLOBULIN G INCREASED | 2 0.02 13.20 BLOOD IRON DECREASED | 4 0.04 13.24 BLOOD IRON INCREASED | 1 0.01 13.25 BLOOD LACTATE DEHYDROGENASE INCREASED | 23 0.23 13.48 BLOOD LACTIC ACID | 1 0.01 13.49 BLOOD LACTIC ACID INCREASED | 1 0.01 13.50 BLOOD MAGNESIUM | 1 0.01 13.51 BLOOD MAGNESIUM DECREASED | 2 0.02 13.53 BLOOD MAGNESIUM INCREASED | 1 0.01 13.54 BLOOD OSMOLARITY | 1 0.01 13.55 BLOOD OSMOLARITY DECREASED | 1 0.01 13.56 BLOOD PH DECREASED | 4 0.04 13.60 BLOOD PH INCREASED | 1 0.01 13.61 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.62 BLOOD POTASSIUM DECREASED | 10 0.10 13.72 BLOOD POTASSIUM INCREASED | 5 0.05 13.77 BLOOD PRESSURE ABNORMAL | 2 0.02 13.79 BLOOD PRESSURE DECREASED | 28 0.28 14.07 BLOOD PRESSURE DIASTOLIC DECREASED | 3 0.03 14.10 BLOOD PRESSURE FLUCTUATION | 3 0.03 14.13 BLOOD PRESSURE IMMEASURABLE | 2 0.02 14.15 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 14.16 BLOOD PRESSURE INCREASED | 26 0.26 14.42 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 14.44 BLOOD PRESSURE SYSTOLIC INCREASED | 6 0.06 14.50 BLOOD PROLACTIN INCREASED | 3 0.03 14.53 BLOOD SODIUM DECREASED | 12 0.12 14.65 BLOOD SODIUM INCREASED | 5 0.05 14.70 BLOOD TEST ABNORMAL | 1 0.01 14.71 BLOOD TRIGLYCERIDES INCREASED | 8 0.08 14.79 BLOOD UREA | 1 0.01 14.80 BLOOD UREA ABNORMAL | 1 0.01 14.81 BLOOD UREA DECREASED | 4 0.04 14.85 BLOOD UREA INCREASED | 14 0.14 14.99 BLOOD URIC ACID INCREASED | 3 0.03 15.02 BLOOD URINE | 1 0.01 15.03 BLOOD URINE PRESENT | 1 0.01 15.04 BODY HEIGHT DECREASED | 1 0.01 15.05 BODY MASS INDEX INCREASED | 1 0.01 15.06 BODY TEMPERATURE DECREASED | 6 0.06 15.12 BODY TEMPERATURE INCREASED | 10 0.10 15.22 BODY TINEA | 1 0.01 15.23 BONE DEBRIDEMENT | 1 0.01 15.24 BONE DENSITY DECREASED | 3 0.03 15.27 BONE DISORDER | 1 0.01 15.28 BONE MARROW DEPRESSION | 9 0.09 15.37 BONE MARROW DISORDER | 3 0.03 15.40 BONE MARROW TRANSPLANT | 1 0.01 15.41 BONE NEOPLASM | 1 0.01 15.42 BONE PAIN | 8 0.08 15.50 BORDERLINE PERSONALITY DISORDER | 1 0.01 15.51 BOTULISM | 1 0.01 15.52 BOWEL SOUNDS ABNORMAL | 2 0.02 15.54 BRACHYCEPHALY | 1 0.01 15.55 BRADYARRHYTHMIA | 2 0.02 15.57 BRADYCARDIA | 14 0.14 15.71 BRADYCARDIA FOETAL | 1 0.01 15.72 BRADYPHRENIA | 3 0.03 15.75 BRAIN ABSCESS | 1 0.01 15.76 BRAIN CONTUSION | 1 0.01 15.77 BRAIN DAMAGE | 1 0.01 15.78 BRAIN DEATH | 4 0.04 15.82 BRAIN HERNIATION | 1 0.01 15.83 BRAIN NEOPLASM | 3 0.03 15.86 BRAIN NEOPLASM BENIGN | 1 0.01 15.87 BRAIN OEDEMA | 4 0.04 15.91 BRAIN SCAN ABNORMAL | 2 0.02 15.93 BRAIN STEM AUDITORY EVOKED RESPONSE A.. | 1 0.01 15.94 BREAST CANCER | 9 0.09 16.03 BREAST CANCER FEMALE | 1 0.01 16.04 BREAST CANCER IN SITU | 1 0.01 16.05 BREAST CANCER METASTATIC | 1 0.01 16.06 BREAST CANCER RECURRENT | 2 0.02 16.08 BREAST CANCER STAGE I | 1 0.01 16.09 BREAST CYST | 1 0.01 16.10 BREAST ENGORGEMENT | 2 0.02 16.12 BREAST INFECTION | 1 0.01 16.13 BREAST MASS | 2 0.02 16.15 BREAST NECROSIS | 1 0.01 16.16 BREAST NEOPLASM | 1 0.01 16.17 BREAST PAIN | 5 0.05 16.22 BREAST TENDERNESS | 4 0.04 16.26 BREATH HOLDING | 1 0.01 16.27 BREATH SOUNDS DECREASED | 1 0.01 16.28 BREECH PRESENTATION | 2 0.02 16.30 BRONCHIAL OBSTRUCTION | 1 0.01 16.31 BRONCHIECTASIS | 1 0.01 16.32 BRONCHIOLITIS | 1 0.01 16.33 BRONCHITIS | 10 0.10 16.43 BRONCHITIS ACUTE | 2 0.02 16.45 BRONCHITIS CHRONIC | 1 0.01 16.46 BRONCHOPNEUMONIA | 5 0.05 16.51 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 16.53 BRONCHOSPASM | 3 0.03 16.56 BUNDLE BRANCH BLOCK | 1 0.01 16.57 BUNDLE BRANCH BLOCK LEFT | 8 0.08 16.65 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 16.67 BUNION | 1 0.01 16.68 BURNING SENSATION | 8 0.08 16.76 C-REACTIVE PROTEIN DECREASED | 1 0.01 16.77 C-REACTIVE PROTEIN INCREASED | 21 0.21 16.98 CACHEXIA | 3 0.03 17.01 CAESAREAN SECTION | 14 0.14 17.15 CALCINOSIS | 2 0.02 17.17 CALCIUM METABOLISM DISORDER | 2 0.02 17.19 CALCULUS URINARY | 1 0.01 17.20 CANCER PAIN | 2 0.02 17.22 CANDIDA SEPSIS | 3 0.03 17.25 CANDIDIASIS | 10 0.10 17.35 CAPUT MEDUSAE | 1 0.01 17.36 CARBOHYDRATE ANTIGEN 19-9 INCREASED | 1 0.01 17.37 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 17.38 CARCINOID TUMOUR | 1 0.01 17.39 CARCINOMA | 8 0.08 17.47 CARDIAC ARREST | 26 0.26 17.73 CARDIAC ARREST NEONATAL | 1 0.01 17.74 CARDIAC DISORDER | 6 0.06 17.80 CARDIAC FAILURE | 27 0.27 18.07 CARDIAC FAILURE ACUTE | 4 0.04 18.11 CARDIAC FAILURE CHRONIC | 1 0.01 18.12 CARDIAC FAILURE CONGESTIVE | 22 0.22 18.34 CARDIAC MURMUR | 3 0.03 18.37 CARDIAC OUTPUT DECREASED | 1 0.01 18.38 CARDIAC PROCEDURE COMPLICATION | 2 0.02 18.40 CARDIAC TAMPONADE | 1 0.01 18.41 CARDIAC VALVE VEGETATION | 1 0.01 18.42 CARDIO-RESPIRATORY ARREST | 20 0.20 18.62 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 18.63 CARDIOGENIC SHOCK | 2 0.02 18.65 CARDIOMEGALY | 11 0.11 18.76 CARDIOMYOPATHY | 6 0.06 18.82 CARDIOTOXICITY | 1 0.01 18.83 CARDIOVASCULAR DISORDER | 5 0.05 18.88 CAROTID ARTERY STENOSIS | 3 0.03 18.91 CAROTID ARTERY THROMBOSIS | 1 0.01 18.92 CATARACT | 6 0.06 18.98 CATARACT OPERATION | 1 0.01 18.99 CATATONIA | 1 0.01 19.00 CATHETER RELATED COMPLICATION | 3 0.03 19.03 CATHETER RELATED INFECTION | 8 0.08 19.11 CATHETER SEPSIS | 1 0.01 19.12 CATHETER SITE HAEMORRHAGE | 1 0.01 19.13 CATHETERISATION CARDIAC ABNORMAL | 1 0.01 19.14 CD4 LYMPHOCYTES DECREASED | 1 0.01 19.15 CELLULITIS | 11 0.11 19.26 CENTRAL LINE INFECTION | 1 0.01 19.27 CENTRAL NERVOUS SYSTEM MASS | 1 0.01 19.28 CEREBELLAR HAEMORRHAGE | 1 0.01 19.29 CEREBRAL ARTERY OCCLUSION | 1 0.01 19.30 CEREBRAL ATROPHY | 5 0.05 19.35 CEREBRAL DISORDER | 1 0.01 19.36 CEREBRAL HAEMORRHAGE | 4 0.04 19.40 CEREBRAL HAEMORRHAGE NEONATAL | 1 0.01 19.41 CEREBRAL INFARCTION | 6 0.06 19.47 CEREBRAL ISCHAEMIA | 1 0.01 19.48 CEREBROVASCULAR ACCIDENT | 23 0.23 19.71 CEREBROVASCULAR DISORDER | 1 0.01 19.72 CERVICAL INCOMPETENCE | 1 0.01 19.73 CERVICAL VERTEBRAL FRACTURE | 1 0.01 19.74 CERVICITIS | 1 0.01 19.75 CHANGE OF BOWEL HABIT | 2 0.02 19.77 CHEST DISCOMFORT | 18 0.18 19.95 CHEST PAIN | 50 0.50 20.45 CHEST WALL PAIN | 10 0.10 20.55 CHEST X-RAY ABNORMAL | 3 0.03 20.58 CHILLS | 31 0.31 20.89 CHOKING | 3 0.03 20.92 CHOLANGIOLITIS | 1 0.01 20.93 CHOLANGITIS | 1 0.01 20.94 CHOLECYSTITIS | 3 0.03 20.97 CHOLECYSTITIS ACUTE | 2 0.02 20.99 CHOLELITHIASIS | 10 0.10 21.09 CHOLESTASIS | 10 0.10 21.19 CHONDROMALACIA | 1 0.01 21.20 CHOREOATHETOSIS | 1 0.01 21.21 CHOROIDAL NEOVASCULARISATION | 1 0.01 21.22 CHOROIDITIS | 1 0.01 21.23 CHROMATURIA | 4 0.04 21.27 CHROMOSOME ABNORMALITY | 1 0.01 21.28 CHRONIC HEPATITIS | 1 0.01 21.29 CHRONIC LEUKAEMIA | 1 0.01 21.30 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 5 0.05 21.35 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 3 0.03 21.38 CIRCULATORY COLLAPSE | 9 0.09 21.47 CIRCUMORAL OEDEMA | 1 0.01 21.48 CLAVICLE FRACTURE | 1 0.01 21.49 CLEFT LIP AND PALATE | 3 0.03 21.52 CLINODACTYLY | 1 0.01 21.53 CLONUS | 1 0.01 21.54 CLOSTRIDIAL INFECTION | 2 0.02 21.56 CLOSTRIDIUM COLITIS | 3 0.03 21.59 CLOSTRIDIUM DIFFICILE TOXIN TEST | 1 0.01 21.60 CLUBBING | 1 0.01 21.61 CLUSTER HEADACHE | 1 0.01 21.62 COAGULATION FACTOR VIII LEVEL INCREASED | 2 0.02 21.64 COAGULOPATHY | 8 0.08 21.72 COCCYDYNIA | 1 0.01 21.73 COELIAC DISEASE | 3 0.03 21.76 COGNITIVE DISORDER | 4 0.04 21.80 COLD SWEAT | 5 0.05 21.85 COLITIS | 3 0.03 21.88 COLITIS ISCHAEMIC | 4 0.04 21.92 COLITIS ULCERATIVE | 2 0.02 21.94 COLON CANCER | 2 0.02 21.96 COLON CANCER METASTATIC | 1 0.01 21.97 COLON CANCER STAGE III | 1 0.01 21.98 COLON CANCER STAGE IV | 1 0.01 21.99 COLON OPERATION | 1 0.01 22.00 COLONIC POLYP | 2 0.02 22.02 COLONIC STENOSIS | 1 0.01 22.03 COLOUR BLINDNESS | 1 0.01 22.04 COMA | 49 0.49 22.53 COMA HEPATIC | 1 0.01 22.54 COMMUNICATION DISORDER | 2 0.02 22.56 COMPARTMENT SYNDROME | 1 0.01 22.57 COMPLETED SUICIDE | 20 0.20 22.77 COMPLEX PARTIAL SEIZURES | 1 0.01 22.78 COMPLICATION OF PREGNANCY | 1 0.01 22.79 COMPLICATIONS OF MATERNAL EXPOSURE TO.. | 17 0.17 22.96 COMPLICATIONS OF TRANSPLANT SURGERY | 1 0.01 22.97 COMPRESSION FRACTURE | 2 0.02 22.99 COMPUTERISED TOMOGRAM ABNORMAL | 3 0.03 23.02 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 23.03 CONCUSSION | 2 0.02 23.05 CONDITION AGGRAVATED | 61 0.61 23.66 CONDUCTION DISORDER | 1 0.01 23.67 CONFUSIONAL STATE | 43 0.43 24.10 CONGENITAL ANOMALY | 4 0.04 24.14 CONGENITAL ATRIAL SEPTAL DEFECT | 1 0.01 24.15 CONGENITAL EYE DISORDER | 2 0.02 24.17 CONGENITAL FACIAL NERVE HYPOPLASIA | 1 0.01 24.18 CONGENITAL GENITAL MALFORMATION MALE | 1 0.01 24.19 CONGENITAL HAND MALFORMATION | 1 0.01 24.20 CONGENITAL NAIL DISORDER | 3 0.03 24.23 CONGENITAL NOSE MALFORMATION | 2 0.02 24.25 CONGESTIVE CARDIOMYOPATHY | 4 0.04 24.29 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 24.30 CONJUNCTIVAL HYPERAEMIA | 1 0.01 24.31 CONJUNCTIVITIS | 1 0.01 24.32 CONSCIOUSNESS FLUCTUATING | 1 0.01 24.33 CONSTIPATION | 19 0.19 24.52 CONTUSION | 9 0.09 24.61 CONVERSION DISORDER | 2 0.02 24.63 CONVULSION | 55 0.55 25.18 CONVULSIVE THRESHOLD LOWERED | 2 0.02 25.20 COOMBS TEST POSITIVE | 1 0.01 25.21 COORDINATION ABNORMAL | 2 0.02 25.23 COR PULMONALE | 1 0.01 25.24 CORNEAL DYSTROPHY | 1 0.01 25.25 CORNEAL GRAFT REJECTION | 1 0.01 25.26 CORNEAL OEDEMA | 1 0.01 25.27 CORNEAL SCAR | 1 0.01 25.28 CORONARY ARTERIAL STENT INSERTION | 2 0.02 25.30 CORONARY ARTERY ATHEROSCLEROSIS | 10 0.10 25.40 CORONARY ARTERY DISEASE | 7 0.07 25.47 CORONARY ARTERY OCCLUSION | 5 0.05 25.52 CORONARY ARTERY STENOSIS | 5 0.05 25.57 CORONARY ARTERY SURGERY | 1 0.01 25.58 CORONARY ARTERY THROMBOSIS | 2 0.02 25.60 COUGH | 25 0.25 25.85 CRACKLES LUNG | 2 0.02 25.87 CRANIOSYNOSTOSIS | 1 0.01 25.88 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 25.89 CREATININE RENAL CLEARANCE INCREASED | 1 0.01 25.90 CREPITATIONS | 1 0.01 25.91 CROHN'S DISEASE | 1 0.01 25.92 CROSS SENSITIVITY REACTION | 1 0.01 25.93 CRUSH SYNDROME | 1 0.01 25.94 CRYING | 10 0.10 26.04 CRYPTORCHISM | 1 0.01 26.05 CSF NEUTROPHIL COUNT INCREASED | 1 0.01 26.06 CSF PROTEIN INCREASED | 1 0.01 26.07 CSF WHITE BLOOD CELL COUNT INCREASED | 1 0.01 26.08 CULTURE POSITIVE | 1 0.01 26.09 CULTURE URINE POSITIVE | 1 0.01 26.10 CULTURE WOUND POSITIVE | 3 0.03 26.13 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 26.14 CUTANEOUS VASCULITIS | 1 0.01 26.15 CYANOSIS | 13 0.13 26.28 CYANOSIS CENTRAL | 2 0.02 26.30 CYST | 1 0.01 26.31 CYSTITIS | 5 0.05 26.36 CYTOLYTIC HEPATITIS | 9 0.09 26.45 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 1 0.01 26.46 CYTOMEGALOVIRUS INFECTION | 2 0.02 26.48 DEAFNESS | 4 0.04 26.52 DEAFNESS NEUROSENSORY | 2 0.02 26.54 DEAFNESS UNILATERAL | 1 0.01 26.55 DEATH | 38 0.38 26.93 DECREASED ACTIVITY | 2 0.02 26.95 DECREASED APPETITE | 14 0.14 27.09 DECUBITUS ULCER | 1 0.01 27.10 DEEP VEIN THROMBOSIS | 11 0.11 27.21 DEHYDRATION | 38 0.38 27.59 DELAYED ENGRAFTMENT | 1 0.01 27.60 DELAYED FONTANELLE CLOSURE | 2 0.02 27.62 DELIRIUM | 4 0.04 27.66 DELIRIUM TREMENS | 1 0.01 27.67 DELUSION | 2 0.02 27.69 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 27.70 DEMENTIA | 1 0.01 27.71 DEMYELINATING POLYNEUROPATHY | 1 0.01 27.72 DENTAL EXAMINATION ABNORMAL | 1 0.01 27.73 DEPENDENCE | 4 0.04 27.77 DEPRESSED LEVEL OF CONSCIOUSNESS | 36 0.36 28.13 DEPRESSED MOOD | 3 0.03 28.16 DEPRESSION | 41 0.41 28.57 DERMAL CYST | 1 0.01 28.58 DERMATITIS | 2 0.02 28.60 DERMATITIS ACNEIFORM | 1 0.01 28.61 DERMATITIS BULLOUS | 3 0.03 28.64 DERMATITIS CONTACT | 2 0.02 28.66 DERMATITIS EXFOLIATIVE | 4 0.04 28.70 DERMOID CYST | 1 0.01 28.71 DEVELOPMENTAL COORDINATION DISORDER | 2 0.02 28.73 DEVELOPMENTAL DELAY | 1 0.01 28.74 DEVICE FAILURE | 3 0.03 28.77 DIABETES INSIPIDUS | 3 0.03 28.80 DIABETES MELLITUS | 13 0.13 28.93 DIABETES MELLITUS INADEQUATE CONTROL | 4 0.04 28.97 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 5 0.05 29.02 DIABETIC COMA | 1 0.01 29.03 DIABETIC HYPEROSMOLAR COMA | 2 0.02 29.05 DIABETIC KETOACIDOSIS | 3 0.03 29.08 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC .. | 1 0.01 29.09 DIABETIC NEPHROPATHY | 1 0.01 29.10 DIALYSIS | 14 0.14 29.24 DIAPHRAGMATIC INJURY | 1 0.01 29.25 DIARRHOEA | 69 0.69 29.94 DIARRHOEA HAEMORRHAGIC | 2 0.02 29.96 DIASTOLIC DYSFUNCTION | 1 0.01 29.97 DIFFICULTY IN WALKING | 26 0.26 30.23 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 30.24 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT | 1 0.01 30.25 DILATATION INTRAHEPATIC DUCT ACQUIRED | 1 0.01 30.26 DILATATION VENTRICULAR | 1 0.01 30.27 DIPLOPIA | 7 0.07 30.34 DISABILITY | 1 0.01 30.35 DISCOMFORT | 1 0.01 30.36 DISEASE PROGRESSION | 9 0.09 30.45 DISEASE RECURRENCE | 7 0.07 30.52 DISINHIBITION | 1 0.01 30.53 DISORIENTATION | 19 0.19 30.72 DISSEMINATED INTRAVASCULAR COAGULATION | 12 0.12 30.84 DISSOCIATION | 1 0.01 30.85 DISTURBANCE IN ATTENTION | 12 0.12 30.97 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 30.98 DIVERTICULITIS | 1 0.01 30.99 DIVERTICULUM | 3 0.03 31.02 DIVERTICULUM INTESTINAL | 2 0.02 31.04 DIVERTICULUM INTESTINAL HAEMORRHAGIC | 1 0.01 31.05 DIZZINESS | 86 0.86 31.91 DIZZINESS POSTURAL | 1 0.01 31.92 DNA ANTIBODY POSITIVE | 1 0.01 31.93 DROOLING | 2 0.02 31.95 DRUG ABUSER | 8 0.08 32.03 DRUG DEPENDENCE | 20 0.20 32.23 DRUG EFFECT DECREASED | 13 0.13 32.36 DRUG EFFECT PROLONGED | 2 0.02 32.38 DRUG ERUPTION | 7 0.07 32.45 DRUG EXPOSURE DURING PREGNANCY | 18 0.18 32.63 DRUG HYPERSENSITIVITY | 13 0.13 32.76 DRUG INEFFECTIVE | 64 0.64 33.40 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 3 0.03 33.43 DRUG INTERACTION | 54 0.54 33.97 DRUG INTERACTION POTENTIATION | 1 0.01 33.98 DRUG INTOLERANCE | 2 0.02 34.00 DRUG LEVEL ABOVE THERAPEUTIC | 2 0.02 34.02 DRUG LEVEL BELOW THERAPEUTIC | 2 0.02 34.04 DRUG LEVEL DECREASED | 3 0.03 34.07 DRUG LEVEL INCREASED | 16 0.16 34.23 DRUG RESISTANCE | 2 0.02 34.25 DRUG SCREEN POSITIVE | 8 0.08 34.33 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 34.34 DRUG TOLERANCE | 2 0.02 34.36 DRUG TOLERANCE DECREASED | 1 0.01 34.37 DRUG TOXICITY | 25 0.25 34.62 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 34.63 DRUG WITHDRAWAL SYNDROME | 35 0.35 34.98 DRUG WITHDRAWAL SYNDROME NEONATAL | 3 0.03 35.01 DRY MOUTH | 15 0.15 35.16 DRY SKIN | 1 0.01 35.17 DRY THROAT | 1 0.01 35.18 DUODENAL OBSTRUCTION | 1 0.01 35.19 DUODENAL STENOSIS | 1 0.01 35.20 DUODENAL ULCER | 5 0.05 35.25 DUODENAL ULCER HAEMORRHAGE | 1 0.01 35.26 DUODENAL ULCER PERFORATION | 1 0.01 35.27 DUODENITIS | 2 0.02 35.29 DYSARTHRIA | 14 0.14 35.43 DYSGEUSIA | 8 0.08 35.51 DYSKINESIA | 12 0.12 35.63 DYSLALIA | 1 0.01 35.64 DYSMENORRHOEA | 1 0.01 35.65 DYSPEPSIA | 22 0.22 35.87 DYSPHAGIA | 18 0.18 36.05 DYSPHASIA | 1 0.01 36.06 DYSPHEMIA | 1 0.01 36.07 DYSPHONIA | 1 0.01 36.08 DYSPNOEA | 96 0.96 37.04 DYSPNOEA AT REST | 1 0.01 37.05 DYSPNOEA EXACERBATED | 1 0.01 37.06 DYSPNOEA EXERTIONAL | 3 0.03 37.09 DYSSTASIA | 4 0.04 37.13 DYSTONIA | 8 0.08 37.21 DYSURIA | 9 0.09 37.30 EAR PAIN | 1 0.01 37.31 EATING DISORDER | 3 0.03 37.34 ECCHYMOSIS | 3 0.03 37.37 ECZEMA | 10 0.10 37.47 EJACULATION FAILURE | 2 0.02 37.49 EJECTION FRACTION DECREASED | 3 0.03 37.52 ELECTRIC SHOCK | 1 0.01 37.53 ELECTROCARDIOGRAM ABNORMAL | 7 0.07 37.60 ELECTROCARDIOGRAM CHANGE | 1 0.01 37.61 ELECTROCARDIOGRAM POOR R-WAVE PROGRES.. | 1 0.01 37.62 ELECTROCARDIOGRAM PQ INTERVAL | 1 0.01 37.63 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED | 1 0.01 37.64 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 4 0.04 37.68 ELECTROCARDIOGRAM QT PROLONGED | 9 0.09 37.77 ELECTROCARDIOGRAM QT SHORTENED | 1 0.01 37.78 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 37.79 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 2 0.02 37.81 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 37.83 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 5 0.05 37.88 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 37.89 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 37.90 ELECTROCARDIOGRAM ST-T SEGMENT DEPRES.. | 1 0.01 37.91 ELECTROCARDIOGRAM ST-T SEGMENT ELEVAT.. | 1 0.01 37.92 ELECTROCARDIOGRAM T WAVE ABNORMAL | 1 0.01 37.93 ELECTROCARDIOGRAM T WAVE INVERSION | 3 0.03 37.96 ELECTROENCEPHALOGRAM ABNORMAL | 5 0.05 38.01 ELECTROLYTE IMBALANCE | 7 0.07 38.08 ELEVATED MOOD | 1 0.01 38.09 EMBOLIC STROKE | 1 0.01 38.10 EMOTIONAL DISORDER | 5 0.05 38.15 EMOTIONAL DISTRESS | 8 0.08 38.23 EMPYEMA | 1 0.01 38.24 ENCEPHALITIS | 2 0.02 38.26 ENCEPHALOPATHY | 7 0.07 38.33 ENDOCARDIAL FIBROSIS | 1 0.01 38.34 ENDOCARDITIS | 2 0.02 38.36 ENDOMETRIAL CANCER | 1 0.01 38.37 ENDOMETRIAL DISORDER | 1 0.01 38.38 ENDOMETRIOMA | 1 0.01 38.39 ENDOMETRIOSIS | 1 0.01 38.40 ENERGY INCREASED | 2 0.02 38.42 ENLARGED CLITORIS | 1 0.01 38.43 ENTEROBACTER INFECTION | 1 0.01 38.44 ENTEROCOCCAL BACTERAEMIA | 1 0.01 38.45 ENTEROCOCCAL SEPSIS | 1 0.01 38.46 ENTEROCOLITIS | 1 0.01 38.47 ENTEROCOLITIS HAEMORRHAGIC | 2 0.02 38.49 ENURESIS | 1 0.01 38.50 EOSINOPHIL COUNT INCREASED | 5 0.05 38.55 EOSINOPHILIA | 8 0.08 38.63 EOSINOPHILIC PNEUMONIA | 3 0.03 38.66 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 38.67 EOSINOPHILS URINE | 1 0.01 38.68 EOSINOPHILS URINE PRESENT | 1 0.01 38.69 EPENDYMOMA | 1 0.01 38.70 EPIDERMAL NECROSIS | 1 0.01 38.71 EPIGLOTTIS ULCER | 1 0.01 38.72 EPILEPSY | 8 0.08 38.80 EPISTAXIS | 6 0.06 38.86 ERECTILE DYSFUNCTION | 3 0.03 38.89 EROSIVE OESOPHAGITIS | 2 0.02 38.91 ERUCTATION | 2 0.02 38.93 ERYTHEMA | 16 0.16 39.09 ERYTHEMA INDURATUM | 1 0.01 39.10 ERYTHEMA MULTIFORME | 6 0.06 39.16 ERYTHEMA NODOSUM | 3 0.03 39.19 ESCHERICHIA INFECTION | 1 0.01 39.20 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 39.21 EUPHORIC MOOD | 2 0.02 39.23 EUTHYROID SICK SYNDROME | 1 0.01 39.24 EXANTHEM | 6 0.06 39.30 EXCITABILITY | 1 0.01 39.31 EXCORIATION | 1 0.01 39.32 EXERCISE TOLERANCE DECREASED | 1 0.01 39.33 EXOSTOSIS | 1 0.01 39.34 EXSANGUINATION | 1 0.01 39.35 EXTRADURAL HAEMATOMA | 1 0.01 39.36 EXTRASYSTOLES | 1 0.01 39.37 EYE DISORDER | 1 0.01 39.38 EYE HAEMORRHAGE | 5 0.05 39.43 EYE INJURY | 1 0.01 39.44 EYE IRRITATION | 3 0.03 39.47 EYE MOVEMENT DISORDER | 1 0.01 39.48 EYE OEDEMA | 2 0.02 39.50 EYE PAIN | 4 0.04 39.54 EYE REDNESS | 2 0.02 39.56 EYE ROLLING | 2 0.02 39.58 EYE SWELLING | 3 0.03 39.61 EYELID FUNCTION DISORDER | 1 0.01 39.62 EYELID OEDEMA | 2 0.02 39.64 EYELID PTOSIS | 1 0.01 39.65 FACE OEDEMA | 8 0.08 39.73 FACIAL NERVE DISORDER | 1 0.01 39.74 FACIAL PALSY | 4 0.04 39.78 FACIAL PARESIS | 1 0.01 39.79 FAECAL INCONTINENCE | 1 0.01 39.80 FAECAL OCCULT BLOOD POSITIVE | 3 0.03 39.83 FAECALOMA | 3 0.03 39.86 FAECES DISCOLOURED | 3 0.03 39.89 FAILURE TO THRIVE | 1 0.01 39.90 FALL | 47 0.47 40.37 FALLOT'S TETRALOGY | 1 0.01 40.38 FATIGUE | 64 0.64 41.02 FEAR | 9 0.09 41.11 FEAR OF DISEASE | 1 0.01 41.12 FEBRILE BONE MARROW APLASIA | 1 0.01 41.13 FEBRILE NEUTROPENIA | 16 0.16 41.29 FEEDING PROBLEM IN NEWBORN | 1 0.01 41.30 FEELING ABNORMAL | 47 0.47 41.77 FEELING COLD | 6 0.06 41.83 FEELING DRUNK | 1 0.01 41.84 FEELING GUILTY | 1 0.01 41.85 FEELING HOT | 5 0.05 41.90 FEELING JITTERY | 3 0.03 41.93 FEELING OF DESPAIR | 3 0.03 41.96 FEMORAL NECK FRACTURE | 2 0.02 41.98 FEMUR FRACTURE | 5 0.05 42.03 FIBRIN D DIMER INCREASED | 1 0.01 42.04 FIBROMYALGIA | 2 0.02 42.06 FINGER HYPOPLASIA | 1 0.01 42.07 FISTULA | 3 0.03 42.10 FLATULENCE | 5 0.05 42.15 FLUID INTAKE REDUCED | 2 0.02 42.17 FLUID OVERLOAD | 3 0.03 42.20 FLUID RETENTION | 11 0.11 42.31 FLUSHING | 13 0.13 42.44 FOCAL NODULAR HYPERPLASIA | 1 0.01 42.45 FOETAL GROWTH RETARDATION | 5 0.05 42.50 FOETAL HEART RATE DECELERATION | 1 0.01 42.51 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 1 0.01 42.52 FOOD CRAVING | 1 0.01 42.53 FOOD INTERACTION | 2 0.02 42.55 FOOT CRUSHING | 1 0.01 42.56 FOOT FRACTURE | 6 0.06 42.62 FOREIGN BODY ASPIRATION | 1 0.01 42.63 FORMICATION | 3 0.03 42.66 FRACTURE | 1 0.01 42.67 FRACTURE DELAYED UNION | 7 0.07 42.74 FRACTURED ISCHIUM | 1 0.01 42.75 FRACTURED SACRUM | 2 0.02 42.77 FREQUENT BOWEL MOVEMENTS | 2 0.02 42.79 FULL BLOOD COUNT ABNORMAL | 1 0.01 42.80 FUNGAEMIA | 2 0.02 42.82 FUNGAL INFECTION | 2 0.02 42.84 FUNGAL TEST POSITIVE | 1 0.01 42.85 FURUNCLE | 1 0.01 42.86 GAIT DISTURBANCE | 18 0.18 43.04 GALACTORRHOEA | 3 0.03 43.07 GALLBLADDER DISORDER | 4 0.04 43.11 GALLBLADDER OPERATION | 1 0.01 43.12 GALLBLADDER PAIN | 1 0.01 43.13 GAMBLING | 1 0.01 43.14 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 23 0.23 43.37 GAMMOPATHY | 1 0.01 43.38 GANGLION | 1 0.01 43.39 GASTRIC BYPASS | 1 0.01 43.40 GASTRIC CANCER | 4 0.04 43.44 GASTRIC CANCER RECURRENT | 1 0.01 43.45 GASTRIC DISORDER | 2 0.02 43.47 GASTRIC HAEMORRHAGE | 3 0.03 43.50 GASTRIC PERFORATION | 1 0.01 43.51 GASTRIC ULCER | 5 0.05 43.56 GASTRIC ULCER HAEMORRHAGE | 1 0.01 43.57 GASTRIC ULCER PERFORATION | 1 0.01 43.58 GASTRITIS | 5 0.05 43.63 GASTRITIS EROSIVE | 2 0.02 43.65 GASTROENTERITIS | 5 0.05 43.70 GASTROINTESTINAL DISORDER | 10 0.10 43.80 GASTROINTESTINAL HAEMORRHAGE | 13 0.13 43.93 GASTROINTESTINAL INJURY | 6 0.06 43.99 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 44.00 GASTROINTESTINAL NECROSIS | 2 0.02 44.02 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 44.03 GASTROINTESTINAL TOXICITY | 1 0.01 44.04 GASTROOESOPHAGEAL REFLUX DISEASE | 8 0.08 44.12 GAZE PALSY | 1 0.01 44.13 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 44.14 GENERAL PHYSICAL HEALTH DETERIORATION | 21 0.21 44.35 GENERALISED ERYTHEMA | 3 0.03 44.38 GENERALISED OEDEMA | 8 0.08 44.46 GENITOURINARY TRACT INFECTION | 1 0.01 44.47 GENU VARUM | 1 0.01 44.48 GINGIVAL BLEEDING | 4 0.04 44.52 GINGIVAL DISORDER | 1 0.01 44.53 GINGIVAL PAIN | 1 0.01 44.54 GLAUCOMA | 2 0.02 44.56 GLOBULINS INCREASED | 1 0.01 44.57 GLOMERULONEPHRITIS MINIMAL LESION | 1 0.01 44.58 GLOMERULONEPHRITIS PROLIFERATIVE | 1 0.01 44.59 GLOSSITIS | 2 0.02 44.61 GLOSSODYNIA | 4 0.04 44.65 GLUCOSE TOLERANCE IMPAIRED | 4 0.04 44.69 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEF.. | 1 0.01 44.70 GLYCOSURIA | 1 0.01 44.71 GLYCOSYLATED HAEMOGLOBIN DECREASED | 1 0.01 44.72 GLYCOSYLATED HAEMOGLOBIN INCREASED | 4 0.04 44.76 GOITRE | 1 0.01 44.77 GOUT | 2 0.02 44.79 GRAFT COMPLICATION | 2 0.02 44.81 GRAFT THROMBOSIS | 1 0.01 44.82 GRAND MAL CONVULSION | 19 0.19 45.01 GRANULOCYTE COUNT DECREASED | 1 0.01 45.02 GRANULOCYTOPENIA | 2 0.02 45.04 GRANULOMA | 6 0.06 45.10 GROIN PAIN | 2 0.02 45.12 GUILLAIN-BARRE SYNDROME | 1 0.01 45.13 GYNAECOMASTIA | 3 0.03 45.16 HAEMANGIOMA | 2 0.02 45.18 HAEMARTHROSIS | 1 0.01 45.19 HAEMATEMESIS | 11 0.11 45.30 HAEMATOCHEZIA | 9 0.09 45.39 HAEMATOCRIT DECREASED | 17 0.17 45.56 HAEMATOCRIT INCREASED | 1 0.01 45.57 HAEMATOMA | 6 0.06 45.63 HAEMATOTOXICITY | 9 0.09 45.72 HAEMATURIA | 7 0.07 45.79 HAEMODIALYSIS | 16 0.16 45.95 HAEMODYNAMIC INSTABILITY | 1 0.01 45.96 HAEMOGLOBIN ABNORMAL | 3 0.03 45.99 HAEMOGLOBIN DECREASED | 37 0.37 46.36 HAEMOLYSIS | 2 0.02 46.38 HAEMOLYTIC ANAEMIA | 3 0.03 46.41 HAEMOPHILUS INFECTION | 3 0.03 46.44 HAEMOPTYSIS | 8 0.08 46.52 HAEMORRHAGE | 14 0.14 46.66 HAEMORRHAGE INTRACRANIAL | 5 0.05 46.71 HAEMORRHAGIC DIATHESIS | 1 0.01 46.72 HAEMORRHAGIC STROKE | 3 0.03 46.75 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 46.76 HAEMORRHOIDS | 4 0.04 46.80 HAIR COLOUR CHANGES | 1 0.01 46.81 HAIR GROWTH ABNORMAL | 1 0.01 46.82 HALLUCINATION | 17 0.17 46.99 HALLUCINATION, AUDITORY | 5 0.05 47.04 HALLUCINATION, TACTILE | 1 0.01 47.05 HALLUCINATION, VISUAL | 3 0.03 47.08 HALLUCINATIONS, MIXED | 1 0.01 47.09 HANGOVER | 2 0.02 47.11 HEAD INJURY | 8 0.08 47.19 HEADACHE | 71 0.71 47.90 HEARING IMPAIRED | 3 0.03 47.93 HEART INJURY | 1 0.01 47.94 HEART RATE ABNORMAL | 3 0.03 47.97 HEART RATE DECREASED | 8 0.08 48.05 HEART RATE INCREASED | 31 0.31 48.36 HEART RATE IRREGULAR | 5 0.05 48.41 HEAT EXHAUSTION | 1 0.01 48.42 HELICOBACTER INFECTION | 2 0.02 48.44 HEMIANOPIA HETERONYMOUS | 1 0.01 48.45 HEMIPARESIS | 9 0.09 48.54 HEMIPLEGIA | 4 0.04 48.58 HENOCH-SCHONLEIN PURPURA | 1 0.01 48.59 HEPARIN-INDUCED THROMBOCYTOPENIA | 6 0.06 48.65 HEPATIC ADENOMA | 1 0.01 48.66 HEPATIC ATROPHY | 1 0.01 48.67 HEPATIC CIRRHOSIS | 8 0.08 48.75 HEPATIC CONGESTION | 2 0.02 48.77 HEPATIC CYST | 2 0.02 48.79 HEPATIC ENZYME INCREASED | 10 0.10 48.89 HEPATIC FAILURE | 21 0.21 49.10 HEPATIC FIBROSIS | 1 0.01 49.11 HEPATIC FUNCTION ABNORMAL | 15 0.15 49.26 HEPATIC HAEMATOMA | 1 0.01 49.27 HEPATIC HAEMORRHAGE | 1 0.01 49.28 HEPATIC INFARCTION | 1 0.01 49.29 HEPATIC LESION | 2 0.02 49.31 HEPATIC NECROSIS | 12 0.12 49.43 HEPATIC NEOPLASM | 1 0.01 49.44 HEPATIC NEOPLASM MALIGNANT | 3 0.03 49.47 HEPATIC STEATOSIS | 11 0.11 49.58 HEPATIC TRAUMA | 1 0.01 49.59 HEPATITIS | 18 0.18 49.77 HEPATITIS A | 1 0.01 49.78 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 49.79 HEPATITIS ACUTE | 4 0.04 49.83 HEPATITIS B | 5 0.05 49.88 HEPATITIS B ANTIBODY POSITIVE | 1 0.01 49.89 HEPATITIS C | 2 0.02 49.91 HEPATITIS C POSITIVE | 1 0.01 49.92 HEPATITIS CHOLESTATIC | 4 0.04 49.96 HEPATITIS FULMINANT | 5 0.05 50.01 HEPATITIS TOXIC | 3 0.03 50.04 HEPATOCELLULAR DAMAGE | 5 0.05 50.09 HEPATOMEGALY | 6 0.06 50.15 HEPATOSPLENOMEGALY | 3 0.03 50.18 HEPATOTOXICITY | 5 0.05 50.23 HERPES SIMPLEX | 3 0.03 50.26 HERPES VIRUS INFECTION | 1 0.01 50.27 HERPES ZOSTER | 6 0.06 50.33 HIATUS HERNIA | 2 0.02 50.35 HICCUPS | 1 0.01 50.36 HIGH DENSITY LIPOPROTEIN DECREASED | 4 0.04 50.40 HIP ARTHROPLASTY | 3 0.03 50.43 HIP DYSPLASIA | 1 0.01 50.44 HIP FRACTURE | 8 0.08 50.52 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 50.53 HISTOPLASMOSIS | 3 0.03 50.56 HISTOPLASMOSIS CUTANEOUS | 1 0.01 50.57 HOARSENESS | 6 0.06 50.63 HOMICIDAL IDEATION | 6 0.06 50.69 HOSPITALISATION | 2 0.02 50.71 HOSTILITY | 1 0.01 50.72 HOT FLUSH | 4 0.04 50.76 HUMERUS FRACTURE | 1 0.01 50.77 HUNGER | 3 0.03 50.80 HYDROCEPHALUS | 4 0.04 50.84 HYDRONEPHROSIS | 2 0.02 50.86 HYDROTHORAX | 1 0.01 50.87 HYPERACUSIS | 2 0.02 50.89 HYPERAEMIA | 1 0.01 50.90 HYPERAESTHESIA | 2 0.02 50.92 HYPERAMMONAEMIA | 1 0.01 50.93 HYPERBILIRUBINAEMIA | 2 0.02 50.95 HYPERCALCAEMIA | 5 0.05 51.00 HYPERCAPNIA | 2 0.02 51.02 HYPERCHLORHYDRIA | 1 0.01 51.03 HYPERCHOLESTEROLAEMIA | 3 0.03 51.06 HYPERCOAGULATION | 2 0.02 51.08 HYPEREMESIS GRAVIDARUM | 1 0.01 51.09 HYPERGLYCAEMIA | 11 0.11 51.20 HYPERHIDROSIS | 31 0.31 51.51 HYPERKALAEMIA | 16 0.16 51.67 HYPERKERATOSIS | 1 0.01 51.68 HYPERKINESIA | 2 0.02 51.70 HYPERLACTACIDAEMIA | 1 0.01 51.71 HYPERLIPIDAEMIA | 3 0.03 51.74 HYPERPHAGIA | 3 0.03 51.77 HYPERPYREXIA | 2 0.02 51.79 HYPERSENSITIVITY | 27 0.27 52.06 HYPERSOMNIA | 2 0.02 52.08 HYPERSPLENISM ACQUIRED | 1 0.01 52.09 HYPERTELORISM OF ORBIT | 1 0.01 52.10 HYPERTENSION | 39 0.39 52.49 HYPERTENSIVE CRISIS | 1 0.01 52.50 HYPERTENSIVE HEART DISEASE | 1 0.01 52.51 HYPERTHERMIA | 1 0.01 52.52 HYPERTHERMIA MALIGNANT | 1 0.01 52.53 HYPERTHYROIDISM | 4 0.04 52.57 HYPERTONIA | 5 0.05 52.62 HYPERTONIA NEONATAL | 2 0.02 52.64 HYPERTRIGLYCERIDAEMIA | 3 0.03 52.67 HYPERTROPHY BREAST | 2 0.02 52.69 HYPERURICAEMIA | 1 0.01 52.70 HYPERVENTILATION | 4 0.04 52.74 HYPOAESTHESIA | 25 0.25 52.99 HYPOAESTHESIA ORAL | 8 0.08 53.07 HYPOCALCAEMIA | 4 0.04 53.11 HYPOGEUSIA | 2 0.02 53.13 HYPOGLYCAEMIA | 20 0.20 53.33 HYPOGLYCAEMIC SEIZURE | 1 0.01 53.34 HYPOKALAEMIA | 18 0.18 53.52 HYPOKINESIA | 1 0.01 53.53 HYPOMAGNESAEMIA | 3 0.03 53.56 HYPOMANIA | 2 0.02 53.58 HYPONATRAEMIA | 10 0.10 53.68 HYPOPARATHYROIDISM | 2 0.02 53.70 HYPOPHOSPHATAEMIA | 2 0.02 53.72 HYPOPITUITARISM | 1 0.01 53.73 HYPOPNOEA | 1 0.01 53.74 HYPOPROTEINAEMIA | 1 0.01 53.75 HYPOPROTHROMBINAEMIA | 1 0.01 53.76 HYPOREFLEXIA | 1 0.01 53.77 HYPOSPADIAS | 1 0.01 53.78 HYPOTENSION | 42 0.42 54.20 HYPOTHALAMO-PITUITARY DISORDERS | 1 0.01 54.21 HYPOTHERMIA | 2 0.02 54.23 HYPOTHYROIDISM | 8 0.08 54.31 HYPOTONIA | 12 0.12 54.43 HYPOTONIA NEONATAL | 3 0.03 54.46 HYPOTRICHOSIS | 1 0.01 54.47 HYPOVENTILATION | 1 0.01 54.48 HYPOVOLAEMIA | 2 0.02 54.50 HYPOVOLAEMIC SHOCK | 3 0.03 54.53 HYPOXIA | 14 0.14 54.67 HYPOXIC ENCEPHALOPATHY | 2 0.02 54.69 HYSTERECTOMY | 2 0.02 54.71 IATROGENIC INJURY | 3 0.03 54.74 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 54.77 IIIRD NERVE PARALYSIS | 2 0.02 54.79 ILEUS | 6 0.06 54.85 ILEUS PARALYTIC | 1 0.01 54.86 ILLUSION | 1 0.01 54.87 IMMOBILE | 3 0.03 54.90 IMMUNE SYSTEM DISORDER | 3 0.03 54.93 IMMUNODEFICIENCY | 1 0.01 54.94 IMMUNOSUPPRESSION | 2 0.02 54.96 IMPAIRED DRIVING ABILITY | 6 0.06 55.02 IMPAIRED GASTRIC EMPTYING | 1 0.01 55.03 IMPAIRED HEALING | 7 0.07 55.10 IMPAIRED WORK ABILITY | 5 0.05 55.15 IMPLANT SITE INFECTION | 2 0.02 55.17 IMPRISONMENT | 1 0.01 55.18 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 4 0.04 55.22 INCISION SITE HAEMORRHAGE | 1 0.01 55.23 INCISIONAL HERNIA | 1 0.01 55.24 INCOHERENT | 5 0.05 55.29 INCONTINENCE | 3 0.03 55.32 INCREASED APPETITE | 3 0.03 55.35 INCREASED TENDENCY TO BRUISE | 1 0.01 55.36 INDUCED ABORTION FAILED | 4 0.04 55.40 INFECTION | 14 0.14 55.54 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 55.55 INFECTION PROPHYLAXIS | 1 0.01 55.56 INFERTILITY FEMALE | 1 0.01 55.57 INFLAMMATION | 12 0.12 55.69 INFLAMMATION LOCALISED | 1 0.01 55.70 INFLUENZA | 6 0.06 55.76 INFLUENZA LIKE ILLNESS | 16 0.16 55.92 INFREQUENT BOWEL MOVEMENTS | 1 0.01 55.93 INFUSION RELATED REACTION | 2 0.02 55.95 INFUSION SITE BURNING | 1 0.01 55.96 INFUSION SITE INFECTION | 1 0.01 55.97 INFUSION SITE REACTION | 1 0.01 55.98 INJECTION SITE CELLULITIS | 1 0.01 55.99 INJECTION SITE DISCOLOURATION | 1 0.01 56.00 INJECTION SITE ERYTHEMA | 3 0.03 56.03 INJECTION SITE HAEMORRHAGE | 3 0.03 56.06 INJECTION SITE INFECTION | 2 0.02 56.08 INJECTION SITE INFLAMMATION | 1 0.01 56.09 INJECTION SITE NODULE | 1 0.01 56.10 INJECTION SITE OEDEMA | 2 0.02 56.12 INJECTION SITE PAIN | 5 0.05 56.17 INJECTION SITE PARAESTHESIA | 1 0.01 56.18 INJECTION SITE PRURITUS | 1 0.01 56.19 INJECTION SITE REACTION | 1 0.01 56.20 INJECTION SITE SCAR | 1 0.01 56.21 INJECTION SITE SWELLING | 1 0.01 56.22 INJURY | 12 0.12 56.34 INJURY ASPHYXIATION | 2 0.02 56.36 INSOMNIA | 35 0.35 56.71 INSULIN RESISTANCE | 2 0.02 56.73 INSULIN RESISTANT DIABETES | 1 0.01 56.74 INTENTIONAL MISUSE | 3 0.03 56.77 INTENTIONAL OVERDOSE | 17 0.17 56.94 INTENTIONAL SELF-INJURY | 1 0.01 56.95 INTERCOSTAL RETRACTION | 1 0.01 56.96 INTERMITTENT CLAUDICATION | 3 0.03 56.99 INTERNATIONAL NORMALISED RATIO DECREA.. | 3 0.03 57.02 INTERNATIONAL NORMALISED RATIO INCREA.. | 19 0.19 57.21 INTERSTITIAL LUNG DISEASE | 18 0.18 57.39 INTERVERTEBRAL DISC DISORDER | 3 0.03 57.42 INTERVERTEBRAL DISC OPERATION | 1 0.01 57.43 INTERVERTEBRAL DISC PROTRUSION | 2 0.02 57.45 INTERVERTEBRAL DISC SPACE NARROWING | 1 0.01 57.46 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 57.47 INTESTINAL HYPERMOTILITY | 2 0.02 57.49 INTESTINAL ISCHAEMIA | 2 0.02 57.51 INTESTINAL OBSTRUCTION | 1 0.01 57.52 INTESTINAL PERFORATION | 1 0.01 57.53 INTESTINAL POLYP | 1 0.01 57.54 INTESTINAL PROLAPSE | 1 0.01 57.55 INTRA-UTERINE DEATH | 4 0.04 57.59 INTRACARDIAC THROMBUS | 1 0.01 57.60 INTRAOCULAR PRESSURE INCREASED | 1 0.01 57.61 IRON DEFICIENCY ANAEMIA | 1 0.01 57.62 IRRITABILITY | 12 0.12 57.74 IRRITABLE BOWEL SYNDROME | 3 0.03 57.77 ISCHAEMIA | 2 0.02 57.79 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 57.80 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 57.81 ISCHAEMIC HEPATITIS | 1 0.01 57.82 ISCHAEMIC STROKE | 2 0.02 57.84 JAUNDICE | 15 0.15 57.99 JAUNDICE CHOLESTATIC | 3 0.03 58.02 JAUNDICE NEONATAL | 1 0.01 58.03 JAW DISORDER | 1 0.01 58.04 JOINT DISLOCATION | 1 0.01 58.05 JOINT EFFUSION | 1 0.01 58.06 JOINT INJURY | 1 0.01 58.07 JOINT LOCK | 1 0.01 58.08 JOINT SPRAIN | 4 0.04 58.12 JOINT STIFFNESS | 3 0.03 58.15 JOINT SWELLING | 5 0.05 58.20 JUDGEMENT IMPAIRED | 3 0.03 58.23 JUGULAR VEIN DISTENSION | 1 0.01 58.24 KAWASAKI'S DISEASE | 1 0.01 58.25 KERATITIS | 1 0.01 58.26 KERATOACANTHOMA | 1 0.01 58.27 KERATOCONJUNCTIVITIS SICCA | 2 0.02 58.29 KETOACIDOSIS | 2 0.02 58.31 KIDNEY MALFORMATION | 1 0.01 58.32 KIDNEY TRANSPLANT REJECTION | 2 0.02 58.34 KLEBSIELLA INFECTION | 2 0.02 58.36 LABILE BLOOD PRESSURE | 1 0.01 58.37 LABORATORY TEST ABNORMAL | 8 0.08 58.45 LACERATION | 3 0.03 58.48 LACK OF SPONTANEOUS SPEECH | 1 0.01 58.49 LACTIC ACIDOSIS | 9 0.09 58.58 LACUNAR INFARCTION | 3 0.03 58.61 LARGE INTESTINAL OBSTRUCTION | 1 0.01 58.62 LARGE INTESTINAL ULCER | 4 0.04 58.66 LARGE INTESTINE PERFORATION | 4 0.04 58.70 LARYNGEAL CANCER | 1 0.01 58.71 LARYNGEAL OEDEMA | 3 0.03 58.74 LARYNGEAL ULCERATION | 1 0.01 58.75 LARYNGITIS | 2 0.02 58.77 LARYNGOSPASM | 10 0.10 58.87 LATEX ALLERGY | 1 0.01 58.88 LEGAL PROBLEM | 1 0.01 58.89 LEIOMYOMA | 1 0.01 58.90 LETHARGY | 18 0.18 59.08 LEUKAEMIA | 1 0.01 59.09 LEUKOCYTOCLASTIC VASCULITIS | 2 0.02 59.11 LEUKOCYTOSIS | 5 0.05 59.16 LEUKOENCEPHALOPATHY | 1 0.01 59.17 LEUKOPENIA | 14 0.14 59.31 LIBIDO DECREASED | 6 0.06 59.37 LIBIDO DISORDER | 1 0.01 59.38 LIFE SUPPORT | 1 0.01 59.39 LIGAMENT INJURY | 1 0.01 59.40 LIMB INJURY | 2 0.02 59.42 LIMB MALFORMATION | 1 0.01 59.43 LIMB REDUCTION DEFECT | 1 0.01 59.44 LIP DISCOLOURATION | 1 0.01 59.45 LIP DRY | 1 0.01 59.46 LIPASE INCREASED | 3 0.03 59.49 LIPODYSTROPHY ACQUIRED | 2 0.02 59.51 LIVEDO RETICULARIS | 1 0.01 59.52 LIVER DISORDER | 13 0.13 59.65 LIVER FUNCTION TEST ABNORMAL | 18 0.18 59.83 LIVER TRANSPLANT | 2 0.02 59.85 LIVIDITY | 1 0.01 59.86 LOBAR PNEUMONIA | 2 0.02 59.88 LOCAL SWELLING | 1 0.01 59.89 LOCALISED INFECTION | 2 0.02 59.91 LOCALISED OEDEMA | 2 0.02 59.93 LOCALISED OSTEOARTHRITIS | 4 0.04 59.97 LOGORRHOEA | 3 0.03 60.00 LONG QT SYNDROME CONGENITAL | 1 0.01 60.01 LOOSE STOOLS | 4 0.04 60.05 LOSS OF CONSCIOUSNESS | 44 0.44 60.49 LOSS OF EMPLOYMENT | 3 0.03 60.52 LOSS OF LIBIDO | 4 0.04 60.56 LOW DENSITY LIPOPROTEIN INCREASED | 3 0.03 60.59 LOW SET EARS | 2 0.02 60.61 LOWER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 60.65 LOWER LIMB FRACTURE | 4 0.04 60.69 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 60.71 LUDWIG ANGINA | 1 0.01 60.72 LUMBAR PUNCTURE | 1 0.01 60.73 LUMBAR RADICULOPATHY | 2 0.02 60.75 LUMBAR SPINAL STENOSIS | 2 0.02 60.77 LUMBAR VERTEBRAL FRACTURE | 2 0.02 60.79 LUNG ABSCESS | 1 0.01 60.80 LUNG ADENOCARCINOMA | 1 0.01 60.81 LUNG CANCER METASTATIC | 2 0.02 60.83 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 60.84 LUNG CONSOLIDATION | 1 0.01 60.85 LUNG CREPITATION | 1 0.01 60.86 LUNG DISORDER | 5 0.05 60.91 LUNG HYPERINFLATION | 1 0.01 60.92 LUNG INFECTION | 1 0.01 60.93 LUNG INFILTRATION | 6 0.06 60.99 LUNG NEOPLASM | 4 0.04 61.03 LUNG NEOPLASM MALIGNANT | 8 0.08 61.11 LUPUS PNEUMONITIS | 1 0.01 61.12 LUPUS-LIKE SYNDROME | 6 0.06 61.18 LYMPHADENOPATHY | 11 0.11 61.29 LYMPHADENOPATHY MEDIASTINAL | 3 0.03 61.32 LYMPHANGIOSIS CARCINOMATOSA | 2 0.02 61.34 LYMPHANGITIS | 2 0.02 61.36 LYMPHOCELE | 4 0.04 61.40 LYMPHOCELE MARSUPIALISATION | 3 0.03 61.43 LYMPHOCYTE COUNT DECREASED | 3 0.03 61.46 LYMPHOCYTE COUNT INCREASED | 1 0.01 61.47 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 61.48 LYMPHOCYTOSIS | 1 0.01 61.49 LYMPHOEDEMA | 1 0.01 61.50 LYMPHOMA | 4 0.04 61.54 LYMPHOPENIA | 3 0.03 61.57 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 61.59 MACULAR DEGENERATION | 3 0.03 61.62 MACULAR OEDEMA | 1 0.01 61.63 MALABSORPTION | 2 0.02 61.65 MALAISE | 37 0.37 62.02 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 62.03 MALIGNANT FIBROUS HISTIOCYTOMA | 2 0.02 62.05 MALIGNANT MELANOMA | 4 0.04 62.09 MALIGNANT MELANOMA STAGE I | 1 0.01 62.10 MALIGNANT NEOPLASM PROGRESSION | 33 0.33 62.43 MALIGNANT PERITONEAL NEOPLASM | 1 0.01 62.44 MALNUTRITION | 3 0.03 62.47 MAMMOGRAM ABNORMAL | 1 0.01 62.48 MANIA | 7 0.07 62.55 MARKEDLY REDUCED DIETARY INTAKE | 11 0.11 62.66 MARROW HYPERPLASIA | 2 0.02 62.68 MASS | 1 0.01 62.69 MATERNAL DRUGS AFFECTING FOETUS | 22 0.22 62.91 MEAN CELL VOLUME DECREASED | 2 0.02 62.93 MEAN CELL VOLUME INCREASED | 1 0.01 62.94 MECHANICAL COMPLICATION OF IMPLANT | 1 0.01 62.95 MECONIUM IN AMNIOTIC FLUID | 1 0.01 62.96 MECONIUM STAIN | 1 0.01 62.97 MEDICAL DEVICE COMPLICATION | 1 0.01 62.98 MEDICAL DEVICE IMPLANTATION | 1 0.01 62.99 MEDICATION ERROR | 81 0.81 63.80 MELAENA | 9 0.09 63.89 MELAENA NEONATAL | 1 0.01 63.90 MEMORY IMPAIRMENT | 16 0.16 64.06 MENIERE'S DISEASE | 1 0.01 64.07 MENINGIOMA | 1 0.01 64.08 MENINGITIS | 3 0.03 64.11 MENINGITIS CRYPTOCOCCAL | 1 0.01 64.12 MENORRHAGIA | 4 0.04 64.16 MENSTRUATION IRREGULAR | 1 0.01 64.17 MENTAL DISORDER | 7 0.07 64.24 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 1 0.01 64.25 MENTAL IMPAIRMENT | 4 0.04 64.29 MENTAL STATUS CHANGES | 13 0.13 64.42 METABOLIC ACIDOSIS | 9 0.09 64.51 METABOLIC ENCEPHALOPATHY | 2 0.02 64.53 METAMYELOCYTE COUNT INCREASED | 1 0.01 64.54 METASTASES TO ABDOMINAL CAVITY | 1 0.01 64.55 METASTASES TO ADRENALS | 1 0.01 64.56 METASTASES TO BONE | 6 0.06 64.62 METASTASES TO CENTRAL NERVOUS SYSTEM | 5 0.05 64.67 METASTASES TO LIVER | 7 0.07 64.74 METASTASES TO LUNG | 3 0.03 64.77 METASTASES TO LYMPH NODES | 2 0.02 64.79 METASTASES TO PERITONEUM | 1 0.01 64.80 METASTASES TO SKIN | 1 0.01 64.81 METASTASES TO SMALL INTESTINE | 1 0.01 64.82 METASTASES TO SPINE | 1 0.01 64.83 METASTASES TO SPLEEN | 1 0.01 64.84 METASTASIS | 7 0.07 64.91 METASTATIC MALIGNANT MELANOMA | 2 0.02 64.93 METASTATIC NEOPLASM | 2 0.02 64.95 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 1 0.01 64.96 METRORRHAGIA | 2 0.02 64.98 MICROANGIOPATHY | 2 0.02 65.00 MICROCYTIC ANAEMIA | 1 0.01 65.01 MICROGNATHIA | 2 0.02 65.03 MICTURITION DISORDER | 2 0.02 65.05 MIDDLE INSOMNIA | 1 0.01 65.06 MIGRAINE | 9 0.09 65.15 MIGRAINE WITH AURA | 1 0.01 65.16 MIGRATION OF IMPLANT | 1 0.01 65.17 MILK ALLERGY | 1 0.01 65.18 MITOCHONDRIAL CYTOPATHY | 1 0.01 65.19 MITOCHONDRIAL TOXICITY | 1 0.01 65.20 MITRAL VALVE DISEASE | 2 0.02 65.22 MITRAL VALVE INCOMPETENCE | 7 0.07 65.29 MITRAL VALVE PROLAPSE | 1 0.01 65.30 MOBILITY DECREASED | 1 0.01 65.31 MONOCYTE COUNT INCREASED | 3 0.03 65.34 MONONUCLEOSIS SYNDROME | 1 0.01 65.35 MONOPLEGIA | 1 0.01 65.36 MOOD ALTERED | 6 0.06 65.42 MOOD SWINGS | 6 0.06 65.48 MORBID THOUGHTS | 1 0.01 65.49 MOUTH HAEMORRHAGE | 3 0.03 65.52 MOUTH ULCERATION | 3 0.03 65.55 MOVEMENT DISORDER | 2 0.02 65.57 MOYAMOYA DISEASE | 1 0.01 65.58 MUCOSAL DRYNESS | 3 0.03 65.61 MUCOSAL EROSION | 1 0.01 65.62 MUCOSAL HAEMORRHAGE | 1 0.01 65.63 MUCOSAL INFLAMMATION | 9 0.09 65.72 MUCOUS MEMBRANE DISORDER | 1 0.01 65.73 MULTI-ORGAN DISORDER | 1 0.01 65.74 MULTI-ORGAN FAILURE | 22 0.22 65.96 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 65.97 MULTIPLE DRUG OVERDOSE | 21 0.21 66.18 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 66.19 MULTIPLE MYELOMA | 4 0.04 66.23 MULTIPLE SCLEROSIS | 18 0.18 66.41 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 66.43 MUSCLE ATROPHY | 4 0.04 66.47 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 66.49 MUSCLE CRAMP | 17 0.17 66.66 MUSCLE DISORDER | 1 0.01 66.67 MUSCLE ENZYME INCREASED | 1 0.01 66.68 MUSCLE HAEMORRHAGE | 1 0.01 66.69 MUSCLE INJURY | 1 0.01 66.70 MUSCLE NECROSIS | 1 0.01 66.71 MUSCLE RIGIDITY | 8 0.08 66.79 MUSCLE SPASMS | 14 0.14 66.93 MUSCLE TWITCHING | 8 0.08 67.01 MUSCULAR WEAKNESS | 6 0.06 67.07 MUSCULOSKELETAL PAIN | 2 0.02 67.09 MUSCULOSKELETAL STIFFNESS | 7 0.07 67.16 MYALGIA | 32 0.32 67.48 MYASTHENIA GRAVIS | 1 0.01 67.49 MYCOBACTERIA SPUTUM TEST POSITIVE | 1 0.01 67.50 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 67.52 MYCOBACTERIUM CHELONEI INFECTION | 1 0.01 67.53 MYCOPLASMA INFECTION | 2 0.02 67.55 MYDRIASIS | 9 0.09 67.64 MYELITIS TRANSVERSE | 2 0.02 67.66 MYELOCYTE COUNT INCREASED | 1 0.01 67.67 MYELODYSPLASTIC SYNDROME | 7 0.07 67.74 MYELOPROLIFERATIVE DISORDER | 1 0.01 67.75 MYOCARDIAL INFARCTION | 42 0.42 68.17 MYOCARDIAL ISCHAEMIA | 4 0.04 68.21 MYOCARDITIS | 1 0.01 68.22 MYOCLONUS | 6 0.06 68.28 MYOGLOBIN BLOOD INCREASED | 1 0.01 68.29 MYOPATHY | 4 0.04 68.33 NASAL CONGESTION | 2 0.02 68.35 NASAL MUCOSAL DISORDER | 1 0.01 68.36 NASAL NEOPLASM | 1 0.01 68.37 NASOPHARYNGITIS | 8 0.08 68.45 NAUSEA | 107 1.07 69.52 NECK DEFORMITY | 1 0.01 69.53 NECK PAIN | 7 0.07 69.60 NECROSIS | 6 0.06 69.66 NECROTISING FASCIITIS | 1 0.01 69.67 NEEDLE BIOPSY SITE UNSPECIFIED ABNORMAL | 1 0.01 69.68 NEGATIVE THOUGHTS | 1 0.01 69.69 NEONATAL APNOEIC ATTACK | 2 0.02 69.71 NEONATAL CANDIDA INFECTION | 1 0.01 69.72 NEONATAL DISORDER | 6 0.06 69.78 NEONATAL RESPIRATORY DISTRESS SYNDROME | 5 0.05 69.83 NEOPLASM | 1 0.01 69.84 NEOPLASM PROGRESSION | 1 0.01 69.85 NEPHRITIS INTERSTITIAL | 3 0.03 69.88 NEPHROGENIC ANAEMIA | 1 0.01 69.89 NEPHROLITHIASIS | 3 0.03 69.92 NEPHROPATHY | 1 0.01 69.93 NEPHROPATHY TOXIC | 5 0.05 69.98 NEPHROTIC SYNDROME | 2 0.02 70.00 NERVE INJURY | 1 0.01 70.01 NERVOUS SYSTEM DISORDER | 10 0.10 70.11 NERVOUSNESS | 4 0.04 70.15 NEURAL TUBE DEFECT | 1 0.01 70.16 NEURALGIA | 2 0.02 70.18 NEURITIS | 1 0.01 70.19 NEUROFIBROMATOSIS | 1 0.01 70.20 NEUROGENIC BLADDER | 1 0.01 70.21 NEUROLEPTIC MALIGNANT SYNDROME | 4 0.04 70.25 NEUROLOGICAL SYMPTOM | 2 0.02 70.27 NEUROPATHIC PAIN | 2 0.02 70.29 NEUROPATHY | 4 0.04 70.33 NEUROPATHY PERIPHERAL | 4 0.04 70.37 NEUROTOXICITY | 1 0.01 70.38 NEUTROPENIA | 28 0.28 70.66 NEUTROPENIC INFECTION | 1 0.01 70.67 NEUTROPENIC SEPSIS | 1 0.01 70.68 NEUTROPHIL COUNT DECREASED | 10 0.10 70.78 NEUTROPHIL COUNT INCREASED | 3 0.03 70.81 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.82 NEUTROPHILIA | 1 0.01 70.83 NICOTINE DEPENDENCE | 1 0.01 70.84 NIGHT SWEATS | 10 0.10 70.94 NIGHTMARE | 7 0.07 71.01 NIPPLE DISORDER | 1 0.01 71.02 NIPPLE SWELLING | 1 0.01 71.03 NO ADVERSE DRUG EFFECT | 2 0.02 71.05 NO ADVERSE EFFECT | 1 0.01 71.06 NOCARDIOSIS | 1 0.01 71.07 NOCTURIA | 4 0.04 71.11 NODAL OSTEOARTHRITIS | 1 0.01 71.12 NON-HODGKIN'S LYMPHOMA | 4 0.04 71.16 NON-SMALL CELL LUNG CANCER | 1 0.01 71.17 NON-SMALL CELL LUNG CANCER STAGE I | 1 0.01 71.18 NONSPECIFIC REACTION | 1 0.01 71.19 NORMOCHROMIC NORMOCYTIC ANAEMIA | 2 0.02 71.21 NOSOCOMIAL INFECTION | 1 0.01 71.22 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 71.24 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 5 0.05 71.29 NYSTAGMUS | 1 0.01 71.30 OBESITY | 1 0.01 71.31 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 71.33 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 71.35 OCULAR HYPERAEMIA | 1 0.01 71.36 OCULAR ICTERUS | 4 0.04 71.40 OCULOMUCOCUTANEOUS SYNDROME | 1 0.01 71.41 ODYNOPHAGIA | 2 0.02 71.43 OEDEMA | 12 0.12 71.55 OEDEMA MOUTH | 5 0.05 71.60 OEDEMA PERIPHERAL | 48 0.48 72.08 OESOPHAGEAL ACHALASIA | 2 0.02 72.10 OESOPHAGEAL CARCINOMA | 1 0.01 72.11 OESOPHAGEAL DISORDER | 2 0.02 72.13 OESOPHAGEAL OBSTRUCTION | 1 0.01 72.14 OESOPHAGEAL PAIN | 1 0.01 72.15 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 72.16 OESOPHAGEAL STENOSIS | 3 0.03 72.19 OESOPHAGEAL ULCER | 2 0.02 72.21 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 72.22 OESOPHAGITIS | 5 0.05 72.27 OESOPHAGITIS HAEMORRHAGIC | 1 0.01 72.28 OFF LABEL USE | 2 0.02 72.30 OLIGODIPSIA | 1 0.01 72.31 OLIGOHYDRAMNIOS | 3 0.03 72.34 OLIGURIA | 5 0.05 72.39 ONYCHOMYCOSIS | 1 0.01 72.40 OPEN FRACTURE | 1 0.01 72.41 OPEN WOUND | 1 0.01 72.42 OPERATIVE HAEMORRHAGE | 3 0.03 72.45 OPISTHOTONUS | 1 0.01 72.46 OPPORTUNISTIC INFECTION | 2 0.02 72.48 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 72.49 OPTIC NERVE DISORDER | 1 0.01 72.50 OPTIC NEURITIS | 1 0.01 72.51 OPTIC NEURITIS RETROBULBAR | 1 0.01 72.52 ORAL CANDIDIASIS | 3 0.03 72.55 ORAL FUNGAL INFECTION | 1 0.01 72.56 ORAL PAIN | 3 0.03 72.59 ORAL PRURITUS | 2 0.02 72.61 OROPHARYNGEAL SWELLING | 3 0.03 72.64 ORTHOSTATIC HYPOTENSION | 4 0.04 72.68 OSTEITIS DEFORMANS | 2 0.02 72.70 OSTEOARTHRITIS | 1 0.01 72.71 OSTEOGENESIS IMPERFECTA | 1 0.01 72.72 OSTEOMYELITIS | 4 0.04 72.76 OSTEONECROSIS | 3 0.03 72.79 OSTEOPOROSIS | 3 0.03 72.82 OTITIS MEDIA | 1 0.01 72.83 OVARIAN ABSCESS | 1 0.01 72.84 OVARIAN CANCER | 1 0.01 72.85 OVARIAN DISORDER | 1 0.01 72.86 OVARIAN EPITHELIAL CANCER | 1 0.01 72.87 OVERDOSE | 34 0.34 73.21 OXYGEN SATURATION ABNORMAL | 1 0.01 73.22 OXYGEN SATURATION DECREASED | 11 0.11 73.33 PAIN | 42 0.42 73.75 PAIN EXACERBATED | 3 0.03 73.78 PAIN IN EXTREMITY | 48 0.48 74.26 PAIN IN JAW | 1 0.01 74.27 PAIN OF SKIN | 1 0.01 74.28 PALLOR | 4 0.04 74.32 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 3 0.03 74.35 PALPITATIONS | 14 0.14 74.49 PANCREATIC CYST | 2 0.02 74.51 PANCREATIC DISORDER | 2 0.02 74.53 PANCREATIC NECROSIS | 1 0.01 74.54 PANCREATIC PSEUDOCYST | 1 0.01 74.55 PANCREATITIS | 6 0.06 74.61 PANCREATITIS ACUTE | 9 0.09 74.70 PANCREATITIS CHRONIC | 1 0.01 74.71 PANCYTOPENIA | 23 0.23 74.94 PANIC ATTACK | 9 0.09 75.03 PANNICULITIS | 2 0.02 75.05 PARAESTHESIA | 29 0.29 75.34 PARAESTHESIA ORAL | 4 0.04 75.38 PARAGANGLION NEOPLASM BENIGN | 1 0.01 75.39 PARALYSIS | 5 0.05 75.44 PARANOIA | 4 0.04 75.48 PARAPLEGIA | 1 0.01 75.49 PARESIS | 1 0.01 75.50 PARKINSON'S DISEASE | 1 0.01 75.51 PARKINSONISM | 1 0.01 75.52 PARONYCHIA | 1 0.01 75.53 PAROSMIA | 4 0.04 75.57 PAROTID GLAND ENLARGEMENT | 1 0.01 75.58 PAROTITIS | 2 0.02 75.60 PARVOVIRUS B19 SEROLOGY POSITIVE | 1 0.01 75.61 PATELLA FRACTURE | 1 0.01 75.62 PATHOGEN RESISTANCE | 4 0.04 75.66 PATHOLOGICAL FRACTURE | 1 0.01 75.67 PCO2 DECREASED | 5 0.05 75.72 PECTUS EXCAVATUM | 1 0.01 75.73 PELVIC FRACTURE | 2 0.02 75.75 PELVIC PAIN | 1 0.01 75.76 PEMPHIGOID | 2 0.02 75.78 PEMPHIGUS | 1 0.01 75.79 PENIS DISORDER | 1 0.01 75.80 PEPTIC ULCER | 1 0.01 75.81 PERIANAL ABSCESS | 1 0.01 75.82 PERIARTHRITIS | 1 0.01 75.83 PERICARDIAL EFFUSION | 7 0.07 75.90 PERICARDITIS | 4 0.04 75.94 PERICARDITIS CONSTRICTIVE | 2 0.02 75.96 PERINATAL BRAIN DAMAGE | 1 0.01 75.97 PERIODONTAL DISEASE | 1 0.01 75.98 PERIODONTITIS | 1 0.01 75.99 PERIORBITAL OEDEMA | 1 0.01 76.00 PERIPHERAL COLDNESS | 4 0.04 76.04 PERIPHERAL EMBOLISM | 1 0.01 76.05 PERIPHERAL ISCHAEMIA | 2 0.02 76.07 PERIPHERAL OCCLUSIVE DISEASE | 1 0.01 76.08 PERIPHERAL SENSORIMOTOR NEUROPATHY | 1 0.01 76.09 PERIPHERAL VASCULAR DISORDER | 1 0.01 76.10 PERITONEAL DIALYSIS | 2 0.02 76.12 PERITONEAL FLUID ANALYSIS ABNORMAL | 1 0.01 76.13 PERITONEAL HAEMORRHAGE | 2 0.02 76.15 PERITONEAL TUBERCULOSIS | 1 0.01 76.16 PERITONITIS | 6 0.06 76.22 PERITONITIS BACTERIAL | 1 0.01 76.23 PERONEAL NERVE PALSY | 2 0.02 76.25 PERSONALITY CHANGE | 3 0.03 76.28 PERSONALITY DISORDER | 3 0.03 76.31 PETECHIAE | 3 0.03 76.34 PETIT MAL EPILEPSY | 2 0.02 76.36 PEYRONIE'S DISEASE | 1 0.01 76.37 PHARMACEUTICAL PRODUCT COMPLAINT | 65 0.65 77.02 PHARYNGEAL OEDEMA | 1 0.01 77.03 PHARYNGEAL ULCERATION | 1 0.01 77.04 PHARYNGITIS | 1 0.01 77.05 PHARYNGITIS STREPTOCOCCAL | 2 0.02 77.07 PHARYNGOLARYNGEAL PAIN | 9 0.09 77.16 PHLEBITIS | 4 0.04 77.20 PHLEBITIS SUPERFICIAL | 1 0.01 77.21 PHLEBOTHROMBOSIS | 2 0.02 77.23 PHOTODERMATOSIS | 1 0.01 77.24 PHOTOPHOBIA | 2 0.02 77.26 PHOTOPSIA | 1 0.01 77.27 PHOTOSENSITIVITY REACTION | 2 0.02 77.29 PHYSICAL ASSAULT | 2 0.02 77.31 PIGMENTATION DISORDER | 1 0.01 77.32 PIGMENTED NAEVUS | 1 0.01 77.33 PITTING OEDEMA | 2 0.02 77.35 PITUITARY HAEMORRHAGE | 1 0.01 77.36 PITUITARY TUMOUR BENIGN | 1 0.01 77.37 PLACENTAL DISORDER | 1 0.01 77.38 PLAGIOCEPHALY | 1 0.01 77.39 PLASMAPHERESIS | 1 0.01 77.40 PLATELET AGGREGATION | 1 0.01 77.41 PLATELET COUNT DECREASED | 35 0.35 77.76 PLATELET COUNT INCREASED | 6 0.06 77.82 PLATELET DISORDER | 2 0.02 77.84 PLEURAL DISORDER | 1 0.01 77.85 PLEURAL EFFUSION | 19 0.19 78.04 PLEURAL FIBROSIS | 1 0.01 78.05 PLEURISY | 3 0.03 78.08 PLEURITIC PAIN | 1 0.01 78.09 PNEUMOCYSTIS CARINII INFECTION | 1 0.01 78.10 PNEUMOCYSTIS CARINII PNEUMONIA | 3 0.03 78.13 PNEUMONIA | 53 0.53 78.66 PNEUMONIA ASPIRATION | 11 0.11 78.77 PNEUMONIA BACTERIAL | 5 0.05 78.82 PNEUMONIA FUNGAL | 1 0.01 78.83 PNEUMONIA KLEBSIELLA | 1 0.01 78.84 PNEUMONIA LEGIONELLA | 2 0.02 78.86 PNEUMONIA PNEUMOCOCCAL | 1 0.01 78.87 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 78.88 PNEUMONIA STREPTOCOCCAL | 1 0.01 78.89 PNEUMONIA VIRAL | 1 0.01 78.90 PNEUMONITIS | 7 0.07 78.97 PNEUMOTHORAX | 3 0.03 79.00 PO2 DECREASED | 2 0.02 79.02 POISONING | 1 0.01 79.03 POLLAKIURIA | 8 0.08 79.11 POLYARTHRITIS | 1 0.01 79.12 POLYCYSTIC OVARIES | 1 0.01 79.13 POLYDIPSIA | 1 0.01 79.14 POLYMENORRHOEA | 1 0.01 79.15 POLYMYALGIA RHEUMATICA | 1 0.01 79.16 POLYNEUROPATHY | 4 0.04 79.20 POLYSUBSTANCE ABUSE | 2 0.02 79.22 POLYTRAUMATISM | 1 0.01 79.23 POLYURIA | 3 0.03 79.26 PORTAL VEIN STENOSIS | 1 0.01 79.27 POST LAMINECTOMY SYNDROME | 1 0.01 79.28 POST PROCEDURAL COMPLICATION | 15 0.15 79.43 POST PROCEDURAL HAEMORRHAGE | 5 0.05 79.48 POSTICTAL STATE | 2 0.02 79.50 POSTOPERATIVE INFECTION | 1 0.01 79.51 POSTPARTUM HAEMORRHAGE | 2 0.02 79.53 POSTURING | 1 0.01 79.54 PRE-ECLAMPSIA | 1 0.01 79.55 PREALBUMIN DECREASED | 1 0.01 79.56 PREGNANCY | 3 0.03 79.59 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 79.60 PREGNANCY WITH INJECTABLE CONTRACEPTIVE | 1 0.01 79.61 PREMATURE BABY | 10 0.10 79.71 PREMATURE LABOUR | 5 0.05 79.76 PREMATURE RUPTURE OF MEMBRANES | 3 0.03 79.79 PREMATURE SEPARATION OF PLACENTA | 2 0.02 79.81 PREMENSTRUAL SYNDROME | 1 0.01 79.82 PRESCRIBED OVERDOSE | 3 0.03 79.85 PRIMARY SEQUESTRUM | 1 0.01 79.86 PRINZMETAL ANGINA | 1 0.01 79.87 PROCEDURAL COMPLICATION | 3 0.03 79.90 PRODUCTIVE COUGH | 3 0.03 79.93 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 79.94 PROLACTINOMA | 1 0.01 79.95 PROSTATE CANCER | 5 0.05 80.00 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 80.02 PROSTHESIS IMPLANTATION | 1 0.01 80.03 PROTEIN TOTAL DECREASED | 3 0.03 80.06 PROTEIN TOTAL INCREASED | 1 0.01 80.07 PROTEIN URINE PRESENT | 3 0.03 80.10 PROTEINURIA | 3 0.03 80.13 PROTEUS INFECTION | 1 0.01 80.14 PROTHROMBIN TIME PROLONGED | 5 0.05 80.19 PROTHROMBIN TIME RATIO DECREASED | 1 0.01 80.20 PROTHROMBIN TIME SHORTENED | 2 0.02 80.22 PRURIGO | 1 0.01 80.23 PRURITUS | 41 0.41 80.64 PRURITUS GENERALISED | 4 0.04 80.68 PSEUDOMONAL BACTERAEMIA | 1 0.01 80.69 PSEUDOMONAL SEPSIS | 1 0.01 80.70 PSEUDOMONAS INFECTION | 5 0.05 80.75 PSORIASIS | 1 0.01 80.76 PSYCHIATRIC SYMPTOM | 2 0.02 80.78 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 80.79 PSYCHOMOTOR RETARDATION | 1 0.01 80.80 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 80.81 PSYCHOSOMATIC DISEASE | 1 0.01 80.82 PSYCHOTIC DISORDER | 6 0.06 80.88 PSYCHOTIC DISORDER DUE TO A GENERAL M.. | 1 0.01 80.89 PTERYGIUM | 1 0.01 80.90 PUBIC RAMI FRACTURE | 2 0.02 80.92 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 80.93 PULMONARY CONGESTION | 7 0.07 81.00 PULMONARY DYSMATURITY SYNDROME | 2 0.02 81.02 PULMONARY EMBOLISM | 21 0.21 81.23 PULMONARY FIBROSIS | 10 0.10 81.33 PULMONARY HAEMORRHAGE | 1 0.01 81.34 PULMONARY HYPERTENSION | 2 0.02 81.36 PULMONARY INFARCTION | 1 0.01 81.37 PULMONARY INTERSTITIAL EMPHYSEMA SYND.. | 1 0.01 81.38 PULMONARY MASS | 1 0.01 81.39 PULMONARY OEDEMA | 18 0.18 81.57 PULMONARY SARCOIDOSIS | 2 0.02 81.59 PULMONARY THROMBOSIS | 3 0.03 81.62 PULMONARY TOXICITY | 1 0.01 81.63 PULMONARY TUBERCULOSIS | 2 0.02 81.65 PULMONARY VALVE INCOMPETENCE | 1 0.01 81.66 PULMONARY VALVE STENOSIS | 1 0.01 81.67 PULSE ABSENT | 6 0.06 81.73 PULSE PRESSURE DECREASED | 1 0.01 81.74 PUPIL FIXED | 5 0.05 81.79 PUPILLARY REFLEX IMPAIRED | 3 0.03 81.82 PURPURA | 2 0.02 81.84 PURULENCE | 1 0.01 81.85 PYELONEPHRITIS | 4 0.04 81.89 PYOTHORAX | 1 0.01 81.90 PYREXIA | 111 1.11 83.01 QRS AXIS ABNORMAL | 1 0.01 83.02 QUADRIPARESIS | 1 0.01 83.03 RADIAL NERVE PALSY | 1 0.01 83.04 RADIATION INJURY | 2 0.02 83.06 RADICULOPATHY | 1 0.01 83.07 RALES | 5 0.05 83.12 RASH | 29 0.29 83.41 RASH ERYTHEMATOUS | 5 0.05 83.46 RASH GENERALISED | 7 0.07 83.53 RASH MACULO-PAPULAR | 10 0.10 83.63 RASH PAPULAR | 1 0.01 83.64 RASH PRURITIC | 7 0.07 83.71 RASH PUSTULAR | 2 0.02 83.73 RASH SCALY | 1 0.01 83.74 REACTION TO DRUG PRESERVATIVES | 1 0.01 83.75 REBOUND EFFECT | 2 0.02 83.77 RECTAL HAEMORRHAGE | 7 0.07 83.84 RECTAL POLYP | 2 0.02 83.86 RECTAL STENOSIS | 1 0.01 83.87 RECTAL ULCER | 1 0.01 83.88 RECTOCELE | 1 0.01 83.89 RECURRENT CANCER | 1 0.01 83.90 RED BLOOD CELL COUNT DECREASED | 9 0.09 83.99 RED BLOOD CELL SEDIMENTATION RATE INC.. | 6 0.06 84.05 RED MAN SYNDROME | 1 0.01 84.06 REFLEXES ABNORMAL | 2 0.02 84.08 REFLUX GASTRITIS | 1 0.01 84.09 REFLUX OESOPHAGITIS | 2 0.02 84.11 REFUSAL OF TREATMENT BY PATIENT | 5 0.05 84.16 REFUSAL OF TREATMENT BY RELATIVE | 1 0.01 84.17 REGURGITATION OF FOOD | 1 0.01 84.18 RENAL ABSCESS | 1 0.01 84.19 RENAL ARTERY STENOSIS | 3 0.03 84.22 RENAL ATROPHY | 1 0.01 84.23 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 84.25 RENAL COLIC | 1 0.01 84.26 RENAL CYST | 1 0.01 84.27 RENAL DISORDER | 2 0.02 84.29 RENAL EMBOLISM | 1 0.01 84.30 RENAL FAILURE | 43 0.43 84.73 RENAL FAILURE ACUTE | 49 0.49 85.22 RENAL FAILURE CHRONIC | 4 0.04 85.26 RENAL FAILURE NEONATAL | 2 0.02 85.28 RENAL HYPERTENSION | 1 0.01 85.29 RENAL IMPAIRMENT | 12 0.12 85.41 RENAL INJURY | 1 0.01 85.42 RENAL INTERSTITIAL FIBROSIS | 2 0.02 85.44 RENAL NEOPLASM | 1 0.01 85.45 RENAL OSTEODYSTROPHY | 2 0.02 85.47 RENAL PAIN | 2 0.02 85.49 RENAL TRANSPLANT | 1 0.01 85.50 RENAL TUBULAR ACIDOSIS | 2 0.02 85.52 RENAL TUBULAR DISORDER | 3 0.03 85.55 RENAL TUBULAR NECROSIS | 6 0.06 85.61 RENAL VASCULITIS | 1 0.01 85.62 RENIN DECREASED | 1 0.01 85.63 RESPIRATORY ACIDOSIS | 1 0.01 85.64 RESPIRATORY ARREST | 15 0.15 85.79 RESPIRATORY DEPRESSION | 8 0.08 85.87 RESPIRATORY DISORDER | 9 0.09 85.96 RESPIRATORY DISTRESS | 9 0.09 86.05 RESPIRATORY FAILURE | 38 0.38 86.43 RESPIRATORY RATE DECREASED | 6 0.06 86.49 RESPIRATORY RATE INCREASED | 6 0.06 86.55 RESPIRATORY TRACT CONGESTION | 1 0.01 86.56 RESPIRATORY TRACT INFECTION | 1 0.01 86.57 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 86.58 RESTLESS LEGS SYNDROME | 2 0.02 86.60 RESTLESSNESS | 5 0.05 86.65 RESTRICTIVE PULMONARY DISEASE | 3 0.03 86.68 RESUSCITATION | 1 0.01 86.69 RETAINED PLACENTA OR MEMBRANES | 1 0.01 86.70 RETCHING | 2 0.02 86.72 RETICULOCYTE COUNT INCREASED | 1 0.01 86.73 RETINAL DEGENERATION | 2 0.02 86.75 RETINAL DETACHMENT | 3 0.03 86.78 RETINAL DISORDER | 2 0.02 86.80 RETINAL HAEMORRHAGE | 1 0.01 86.81 RETINAL TEAR | 1 0.01 86.82 RETINAL VASCULAR OCCLUSION | 2 0.02 86.84 RETINAL VEIN OCCLUSION | 1 0.01 86.85 RETINOPATHY | 1 0.01 86.86 RETROGRADE AMNESIA | 1 0.01 86.87 RETROPERITONEAL FIBROSIS | 1 0.01 86.88 RETROPERITONEAL HAEMORRHAGE | 1 0.01 86.89 RHABDOMYOLYSIS | 19 0.19 87.08 RHEUMATOID ARTHRITIS | 3 0.03 87.11 RHINITIS | 1 0.01 87.12 RHINITIS ALLERGIC | 2 0.02 87.14 RHINORRHOEA | 2 0.02 87.16 RHONCHI | 2 0.02 87.18 RIB FRACTURE | 3 0.03 87.21 ROAD TRAFFIC ACCIDENT | 12 0.12 87.33 ROSACEA | 1 0.01 87.34 ROTATOR CUFF SYNDROME | 3 0.03 87.37 RUPTURED CEREBRAL ANEURYSM | 1 0.01 87.38 SALIVARY GLAND DISORDER | 1 0.01 87.39 SALIVARY HYPERSECRETION | 1 0.01 87.40 SALMONELLOSIS | 2 0.02 87.42 SALPINGO-OOPHORECTOMY | 1 0.01 87.43 SARCOIDOSIS | 1 0.01 87.44 SCAB | 2 0.02 87.46 SCAR | 3 0.03 87.49 SCHIZOPHRENIA | 1 0.01 87.50 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 87.51 SCHIZOPHRENIFORM DISORDER | 1 0.01 87.52 SCIATICA | 1 0.01 87.53 SCLERAL DISORDER | 1 0.01 87.54 SCLERITIS | 1 0.01 87.55 SCOLIOSIS | 2 0.02 87.57 SCOTOMA | 1 0.01 87.58 SCREAMING | 2 0.02 87.60 SEBORRHOEIC DERMATITIS | 1 0.01 87.61 SEDATION | 6 0.06 87.67 SELECTIVE MUTISM | 1 0.01 87.68 SELF ESTEEM DECREASED | 1 0.01 87.69 SELF INJURIOUS BEHAVIOUR | 2 0.02 87.71 SELF MUTILATION | 1 0.01 87.72 SELF-INDUCED VOMITING | 1 0.01 87.73 SELF-INJURIOUS IDEATION | 2 0.02 87.75 SELF-MEDICATION | 4 0.04 87.79 SEMEN VOLUME DECREASED | 1 0.01 87.80 SENSATION OF HEAVINESS | 2 0.02 87.82 SENSORY DISTURBANCE | 2 0.02 87.84 SENSORY LOSS | 4 0.04 87.88 SEPSIS | 24 0.24 88.12 SEPSIS SYNDROME | 1 0.01 88.13 SEPTIC SHOCK | 9 0.09 88.22 SEROTONIN SYNDROME | 7 0.07 88.29 SERUM FERRITIN DECREASED | 1 0.01 88.30 SERUM FERRITIN INCREASED | 1 0.01 88.31 SERUM SICKNESS | 2 0.02 88.33 SEXUAL DYSFUNCTION | 3 0.03 88.36 SHIFT TO THE LEFT | 1 0.01 88.37 SHOCK | 20 0.20 88.57 SHUNT OCCLUSION | 1 0.01 88.58 SHUNT THROMBOSIS | 1 0.01 88.59 SIMPLE PARTIAL SEIZURES | 1 0.01 88.60 SINOATRIAL BLOCK | 3 0.03 88.63 SINUS ARREST | 2 0.02 88.65 SINUS BRADYCARDIA | 4 0.04 88.69 SINUS DISORDER | 2 0.02 88.71 SINUS TACHYCARDIA | 12 0.12 88.83 SINUSITIS | 10 0.10 88.93 SJOGREN'S SYNDROME | 1 0.01 88.94 SKIN BURNING SENSATION | 1 0.01 88.95 SKIN DESQUAMATION | 3 0.03 88.98 SKIN DISCOLOURATION | 4 0.04 89.02 SKIN FISSURES | 1 0.01 89.03 SKIN HYPERPIGMENTATION | 1 0.01 89.04 SKIN LACERATION | 4 0.04 89.08 SKIN LESION | 5 0.05 89.13 SKIN ODOUR ABNORMAL | 1 0.01 89.14 SKIN OEDEMA | 1 0.01 89.15 SKIN PAPILLOMA | 1 0.01 89.16 SKIN REACTION | 1 0.01 89.17 SKIN TEST POSITIVE | 1 0.01 89.18 SKIN ULCER | 5 0.05 89.23 SKIN WRINKLING | 2 0.02 89.25 SKULL FRACTURE | 1 0.01 89.26 SKULL MALFORMATION | 1 0.01 89.27 SLEEP APNOEA SYNDROME | 2 0.02 89.29 SLEEP DISORDER | 10 0.10 89.39 SLEEP WALKING | 1 0.01 89.40 SLUGGISHNESS | 2 0.02 89.42 SMALL BOWEL ANGIOEDEMA | 1 0.01 89.43 SMALL FOR DATES BABY | 2 0.02 89.45 SMALL INTESTINAL PERFORATION | 1 0.01 89.46 SMALL INTESTINE CARCINOMA | 2 0.02 89.48 SMOKER | 1 0.01 89.49 SNEEZING | 1 0.01 89.50 SNORING | 3 0.03 89.53 SOCIAL AVOIDANT BEHAVIOUR | 2 0.02 89.55 SOMNOLENCE | 42 0.42 89.97 SOPOR | 1 0.01 89.98 SPEECH DISORDER | 18 0.18 90.16 SPERM COUNT DECREASED | 1 0.01 90.17 SPINAL COLUMN STENOSIS | 2 0.02 90.19 SPINAL COMPRESSION FRACTURE | 2 0.02 90.21 SPINAL CORD COMPRESSION | 3 0.03 90.24 SPINAL DISORDER | 1 0.01 90.25 SPINAL FRACTURE | 4 0.04 90.29 SPINAL FUSION ACQUIRED | 1 0.01 90.30 SPINAL HAEMATOMA | 1 0.01 90.31 SPLENIC ABSCESS | 1 0.01 90.32 SPLENOMEGALY | 6 0.06 90.38 SPONDYLITIS | 1 0.01 90.39 SPONDYLOLISTHESIS ACQUIRED | 1 0.01 90.40 SPONDYLOSIS | 2 0.02 90.42 SPONTANEOUS PENILE ERECTION | 1 0.01 90.43 SPUTUM CULTURE POSITIVE | 2 0.02 90.45 SPUTUM DISCOLOURED | 2 0.02 90.47 SPUTUM RETENTION | 1 0.01 90.48 SQUAMOUS CELL CARCINOMA | 1 0.01 90.49 SQUAMOUS CELL CARCINOMA OF SKIN | 2 0.02 90.51 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 90.53 STAPHYLOCOCCAL INFECTION | 12 0.12 90.65 STAPHYLOCOCCAL SEPSIS | 4 0.04 90.69 STATUS EPILEPTICUS | 2 0.02 90.71 STENT OCCLUSION | 3 0.03 90.74 STEVENS-JOHNSON SYNDROME | 7 0.07 90.81 STOMACH DISCOMFORT | 2 0.02 90.83 STOMATITIS | 5 0.05 90.88 STRABISMUS | 1 0.01 90.89 STREPTOCOCCAL INFECTION | 2 0.02 90.91 STREPTOCOCCAL SEPSIS | 1 0.01 90.92 STRESS SYMPTOMS | 7 0.07 90.99 STRIDOR | 3 0.03 91.02 STUPOR | 1 0.01 91.03 SUBARACHNOID HAEMORRHAGE | 3 0.03 91.06 SUBCLAVIAN VEIN THROMBOSIS | 1 0.01 91.07 SUBCUTANEOUS EMPHYSEMA | 1 0.01 91.08 SUBDURAL HAEMATOMA | 3 0.03 91.11 SUDDEN CARDIAC DEATH | 1 0.01 91.12 SUDDEN DEATH | 4 0.04 91.16 SUDDEN INFANT DEATH SYNDROME | 1 0.01 91.17 SUICIDAL IDEATION | 18 0.18 91.35 SUICIDE ATTEMPT | 9 0.09 91.44 SUPERINFECTION | 1 0.01 91.45 SUPERINFECTION LUNG | 1 0.01 91.46 SUPERIOR VENA CAVAL OCCLUSION | 1 0.01 91.47 SUPPRESSED LACTATION | 1 0.01 91.48 SUPRAPUBIC PAIN | 1 0.01 91.49 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 91.52 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 91.55 SURGERY | 4 0.04 91.59 SUTURE RUPTURE | 2 0.02 91.61 SWELLING | 4 0.04 91.65 SWELLING FACE | 15 0.15 91.80 SWOLLEN TONGUE | 2 0.02 91.82 SYNCOPE | 21 0.21 92.03 SYNDACTYLY | 3 0.03 92.06 SYNOVITIS | 1 0.01 92.07 SYSTEMIC CANDIDA | 2 0.02 92.09 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 3 0.03 92.12 SYSTEMIC LUPUS ERYTHEMATOSUS | 2 0.02 92.14 SYSTEMIC SCLEROSIS | 1 0.01 92.15 T-CELL LYMPHOMA STAGE IV | 1 0.01 92.16 TACHYARRHYTHMIA | 2 0.02 92.18 TACHYCARDIA | 19 0.19 92.37 TACHYCARDIA PAROXYSMAL | 1 0.01 92.38 TACHYPNOEA | 4 0.04 92.42 TALIPES | 3 0.03 92.45 TARDIVE DYSKINESIA | 2 0.02 92.47 TEARFULNESS | 1 0.01 92.48 TELANGIECTASIA | 1 0.01 92.49 TEMPERATURE INTOLERANCE | 1 0.01 92.50 TENDON DISORDER | 4 0.04 92.54 TENDON RUPTURE | 3 0.03 92.57 TENDONITIS | 4 0.04 92.61 TENSION | 1 0.01 92.62 TENSION HEADACHE | 1 0.01 92.63 THERAPEUTIC AGENT TOXICITY | 12 0.12 92.75 THERAPY NON-RESPONDER | 5 0.05 92.80 THINKING ABNORMAL | 5 0.05 92.85 THIRST | 6 0.06 92.91 THROAT IRRITATION | 6 0.06 92.97 THROAT TIGHTNESS | 4 0.04 93.01 THROMBOCYTOPENIA | 32 0.32 93.33 THROMBOCYTOPENIC PURPURA | 1 0.01 93.34 THROMBOPHLEBITIS | 1 0.01 93.35 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 93.36 THROMBOSIS | 20 0.20 93.56 THROMBOTIC MICROANGIOPATHY | 1 0.01 93.57 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 93.58 THYROID DISORDER | 1 0.01 93.59 THYROID FUNCTION TEST ABNORMAL | 1 0.01 93.60 THYROID NEOPLASM | 1 0.01 93.61 TIBIA FRACTURE | 1 0.01 93.62 TIC | 1 0.01 93.63 TINEA BLANCA | 1 0.01 93.64 TINNITUS | 18 0.18 93.82 TOE DEFORMITY | 1 0.01 93.83 TONGUE BITING | 2 0.02 93.85 TONGUE DISORDER | 3 0.03 93.88 TONGUE DRY | 1 0.01 93.89 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 93.90 TONGUE OEDEMA | 2 0.02 93.92 TONGUE PARALYSIS | 2 0.02 93.94 TONIC CONVULSION | 1 0.01 93.95 TONSILLITIS | 1 0.01 93.96 TOOTH ABSCESS | 1 0.01 93.97 TOOTH DISCOLOURATION | 2 0.02 93.99 TOOTH EXTRACTION | 5 0.05 94.04 TOOTH INJURY | 1 0.01 94.05 TOOTH LOSS | 1 0.01 94.06 TORSADE DE POINTES | 5 0.05 94.11 TOXIC EPIDERMAL NECROLYSIS | 10 0.10 94.21 TOXIC INDUCED ENCEPHALOPATHY | 1 0.01 94.22 TOXIC SKIN ERUPTION | 6 0.06 94.28 TOXICOLOGIC TEST ABNORMAL | 2 0.02 94.30 TRACHEOBRONCHITIS | 1 0.01 94.31 TRANSFERRIN INCREASED | 1 0.01 94.32 TRANSFERRIN SATURATION DECREASED | 1 0.01 94.33 TRANSIENT ISCHAEMIC ATTACK | 9 0.09 94.42 TRANSPLANT | 1 0.01 94.43 TRANSPLANT REJECTION | 2 0.02 94.45 TREATMENT NONCOMPLIANCE | 23 0.23 94.68 TREMOR | 47 0.47 95.15 TREMOR NEONATAL | 2 0.02 95.17 TRICUSPID VALVE INCOMPETENCE | 2 0.02 95.19 TRIGGER FINGER | 1 0.01 95.20 TRISMUS | 2 0.02 95.22 TROPONIN INCREASED | 1 0.01 95.23 TUBERCULIN TEST POSITIVE | 1 0.01 95.24 TUBERCULOSIS | 2 0.02 95.26 TUMOUR HAEMORRHAGE | 1 0.01 95.27 TUMOUR LYSIS SYNDROME | 3 0.03 95.30 TUMOUR NECROSIS | 1 0.01 95.31 TWIN PREGNANCY | 1 0.01 95.32 TYPE IV HYPERSENSITIVITY REACTION | 3 0.03 95.35 ULCER HAEMORRHAGE | 1 0.01 95.36 ULTRASOUND LIVER ABNORMAL | 1 0.01 95.37 ULTRASOUND SCAN ABNORMAL | 1 0.01 95.38 UNEMPLOYMENT | 2 0.02 95.40 UNEVALUABLE EVENT | 1 0.01 95.41 UNEXPECTED THERAPEUTIC DRUG EFFECT | 1 0.01 95.42 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 95.43 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 95.44 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 95.49 URINARY INCONTINENCE | 5 0.05 95.54 URINARY RETENTION | 6 0.06 95.60 URINARY TRACT DISORDER | 1 0.01 95.61 URINARY TRACT INFECTION | 26 0.26 95.87 URINE ANALYSIS ABNORMAL | 2 0.02 95.89 URINE FLOW DECREASED | 1 0.01 95.90 URINE KETONE BODY PRESENT | 2 0.02 95.92 URINE OSMOLARITY INCREASED | 1 0.01 95.93 URINE OUTPUT DECREASED | 2 0.02 95.95 URINE PHOSPHATE INCREASED | 1 0.01 95.96 URINE POTASSIUM INCREASED | 1 0.01 95.97 URINE URIC ACID ABNORMAL | 1 0.01 95.98 UROBILIN URINE | 1 0.01 95.99 UROBILIN URINE PRESENT | 1 0.01 96.00 UROSEPSIS | 3 0.03 96.03 URTICARIA | 16 0.16 96.19 URTICARIA GENERALISED | 1 0.01 96.20 URTICARIA PAPULAR | 1 0.01 96.21 UTERINE CANCER | 1 0.01 96.22 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 96.23 UTERINE HYPOTONUS | 1 0.01 96.24 UTERINE NEOPLASM | 1 0.01 96.25 UTERINE RUPTURE | 1 0.01 96.26 UTERINE SPASM | 1 0.01 96.27 UTERINE TENDERNESS | 1 0.01 96.28 VAGINAL CANDIDIASIS | 1 0.01 96.29 VAGINAL DISCHARGE | 1 0.01 96.30 VAGINAL DISORDER | 1 0.01 96.31 VAGINAL HAEMORRHAGE | 7 0.07 96.38 VANISHING BILE DUCT SYNDROME | 1 0.01 96.39 VARICES OESOPHAGEAL | 1 0.01 96.40 VASCULAR CALCIFICATION | 1 0.01 96.41 VASCULAR RUPTURE | 1 0.01 96.42 VASCULAR STENOSIS | 1 0.01 96.43 VASCULITIS | 10 0.10 96.53 VASCULITIS NECROTISING | 1 0.01 96.54 VASODILATATION | 2 0.02 96.56 VEIN DISORDER | 1 0.01 96.57 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.58 VENOUS ANGIOMA OF BRAIN | 1 0.01 96.59 VENOUS STENOSIS | 3 0.03 96.62 VENOUS THROMBOSIS LIMB | 1 0.01 96.63 VENTRICULAR ARRHYTHMIA | 2 0.02 96.65 VENTRICULAR ASYSTOLE | 1 0.01 96.66 VENTRICULAR DYSFUNCTION | 3 0.03 96.69 VENTRICULAR EXTRASYSTOLES | 15 0.15 96.84 VENTRICULAR FIBRILLATION | 5 0.05 96.89 VENTRICULAR HYPERTROPHY | 8 0.08 96.97 VENTRICULAR HYPOKINESIA | 3 0.03 97.00 VENTRICULAR TACHYCARDIA | 9 0.09 97.09 VERTIGO | 10 0.10 97.19 VESICOURETERIC REFLUX | 1 0.01 97.20 VIIITH NERVE LESION | 1 0.01 97.21 VIRAL INFECTION | 8 0.08 97.29 VIRILISM | 1 0.01 97.30 VISION BLURRED | 20 0.20 97.50 VISUAL ACUITY REDUCED | 7 0.07 97.57 VISUAL DISTURBANCE | 7 0.07 97.64 VITAL CAPACITY DECREASED | 1 0.01 97.65 VITREOUS DETACHMENT | 2 0.02 97.67 VITREOUS FLOATERS | 3 0.03 97.70 VITREOUS HAEMORRHAGE | 2 0.02 97.72 VOCAL CORD DISORDER | 1 0.01 97.73 VOCAL CORD POLYP | 1 0.01 97.74 VOMITING | 66 0.66 98.40 VON WILLEBRAND'S FACTOR MULTIMERS ABN.. | 2 0.02 98.42 WALKING AID USER | 4 0.04 98.46 WAXY FLEXIBILITY | 1 0.01 98.47 WEIGHT DECREASED | 37 0.37 98.84 WEIGHT GAIN POOR | 1 0.01 98.85 WEIGHT INCREASED | 34 0.34 99.19 WHEEZING | 3 0.03 99.22 WHIPPLE'S DISEASE | 1 0.01 99.23 WHITE BLOOD CELL COUNT | 1 0.01 99.24 WHITE BLOOD CELL COUNT DECREASED | 32 0.32 99.56 WHITE BLOOD CELL COUNT INCREASED | 28 0.28 99.84 WOUND | 2 0.02 99.86 WOUND DEBRIDEMENT | 1 0.01 99.87 WOUND DEHISCENCE | 3 0.03 99.90 WOUND HAEMORRHAGE | 2 0.02 99.92 WOUND INFECTION | 2 0.02 99.94 WOUND NECROSIS | 1 0.01 99.95 WRIST FRACTURE | 3 0.03 99.98 X-RAY OF PELVIS AND HIP ABNORMAL | 1 0.01 99.99 XANTHELASMA | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015